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Abstract
Young adults, especially African American men who have sex with men (MSM) have the
lowest rates of antiretroviral therapy (ART) adherence among all age groups; however,
they experience greater than 50% of all new Human Immunodeficiency Virus (HIV)
infections among individuals 13 to 24 years of age. Despite the availability of ART,
young MSM continue to experience suboptimal rates of adherence and are one of the
most vulnerable populations for contracting HIV. Grounded in the social cognitive
theory, the aim for this quantitative cross-sectional study was to investigate the
relationship between diverse social determinants and ART adherence among young adult
HIV+ MSM age 18-39 living in the state of Georgia (GA). Data obtained from the 2015
GA Medical Monitoring Project were used to conduct the study. The chi-square model
revealed there was no relationship between ART awareness based on medication dose
and schedule but there was a strong positive relationship between ART awareness and
medication instruction adherence with a gamma of .674 (p =.04). The regression analysis
showed race/ethnicity (p = .039) and educational attainment (p = .028) were predictors of
medication instruction adherence. Whites (p < .029, OR = .168) had a higher likelihood
of adhering to instructions than other races/ethnicities. Educational levels (p = .002) were
predictors of medication schedule adherence and those with higher educational levels
were more likely to adhere to medication instructions. These findings provide valuable
knowledge about the association between factors that promote adherence and those that
adversely contribute to suboptimal ART adherence among young HIV+ MSM.
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Section 1: Foundation of the Study and Literature Review
Introduction
Antiretroviral (ART) medication adherence is critically important for controlling
viral replication, maintaining health, and reducing viral transmission, and it is a
significant part of the human immunodeficiency virus (HIV) treatment regimen because
it reduces the amount of HIV in an individual’s blood (CDC, 2019; Kim et al., 2014;
Shaw & Amico, 2016). Optimal and continuous adherence to ART is essential for
maintaining an undetectable level of HIV virus in the blood, which prevents transmission
of the disease. Additionally, ART is vital for preventing the development of acquired
immune deficiency syndrome (AIDS) and increased mortality and morbidity (Shaw &
Amico, 2016). HIV+ adolescents and young adults experience disproportionally high
rates of suboptimal adherence to ART, resulting in poorer health outcomes compared to
adults. According to the Centers for Disease Control and Prevention (CDC, 2018a),
within the United States (U.S.) men who have sex with men (MSM) are at a higher risk
and disproportionately affected by HIV infection than any other population, especially
African Americans (AA). In this regard, AA MSM are considered a key population. Aho
et al. (2014) asserted MSM vulnerability to HIV infection is associated with biologic and
behavioral factors such as unprotected receptive anal sex, partner mixing, and drug use.
Anal sex is the highest-risk sexual behavior for HIV transmission. It was estimated that
the transmission rates for HIV increase by 18 times during anal sex compared to the rate
for vaginal intercourse, resulting in a 1.4% risk of HIV acquisition during one act of
unprotected anal sex (CDC, 2018b).
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Nationally within the United States and globally, young HIV+ adults experience
distinctive obstacles to sustaining optimal adherence secondary to their developmental
stage such as lack of self-efficacy, stigma, and limited to no awareness and knowledge
about the significance of ART (Maskew et al., 2016). Young adults are in a transitional
stage of development, as they are evolving from adolescence to adulthood, which
involves a considerable amount of cognitive and social developmental milestones (Shaw
& Amcio, 2016). This research may assist in developing interventions that mitigate
obstacles to optimizing ART adherence in young adults. According to Shaw & Amcio
(2016), national studies have been conducted to address ART adherence among MSM,
but adolescents and young adults are vastly underrepresented in evidence-based
adherence interventions, despite their varied and distinct needs and obstacles.
I will investigate relationships between factors that influence ART adherence,
which include social determinants (age, ethnicity, educational attainment, income, and
ART insurance coverage), engagement in care, viral load suppression, and ART
adherence among young adult MSM who are HIV+ between the ages of 18 and 39 in the
state of Georgia. Viral Suppression occurs when HIV medications decreases the amount
of HIV in the body (viral load) to undetectable levels, which keeps the immune system
working and prevents illness (CDC, 2019). Adolescents and young adults are individuals
who range in age from 15 to 39 (Isenalumhe, Fridgen, Beaupin, Quinn, & Reed, 2016;
Lang, David & Giese-Davis, 2015).
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There is a need for public health practitioners and researchers to develop a
combination of preventative tactics and intervention strategies that concentrate on
individual behavior change and biomedical and structural interventions within a
contextual perspective. Knowledge attained from the study may provide a more
comprehensive understanding of how to reduce the progression of HIV to AIDS and
death. The study has implications for positive social change, as it may lead to sustainable
reductions in MSM nonadherence to ART for HIV + youth under the age of 18. Public
health practitioners may be able to use the results of this study to reduce HIV
transmission and mortality rates among young HIV+ MSM while also increasing all
HIV+ MSM awareness of life-saving resources.
In support of public health practitioners and researchers need to investigate the
association between social determinants and young adult adherence to ART, Section 1
will include the problem and purpose statements. It will also include the research
questions, hypotheses, framework, theoretical foundation and nature of the study. Lastly,
Section 1 will contain the literature review, definitions, assumptions, scope,
delimitations, significance, summary, and conclusion.
Problem Statement
Young adults, especially AA MSM, have the lowest rates of ART adherence
among all age groups; however, they experience greater 50% of all new HIV infections
among individuals 13 to 24 years of age and have HIV rates that are three to five times
higher than other ethnic groups (Voisin et al., 2017). Despite the availability of
biomedical interventions such as ART, young MSM continue to experience suboptimal
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rates of adherence and are recognized as one of the most vulnerable populations for HIV
infection (Bekker & Hosek, 2015; Voisin, Quinn, Kim & Schnieder, 2017). Young adults
have distinct needs relative to HIV prevention interventions and secondary to their
developmental status as well as limited awareness, confidence, and interpersonal skills,
which may lead to indulgence in terms of behaviors that increase their potential to
contract HIV (Pettifor et al., 2013). There is limited evidence to support how youth
comprehend, seek, and retain care and recognize the significance of HIV testing and
prevention services as well as the dynamics that influence the efficiency of biomedical
prevention strategies (Kurth, Lally, Choko, Inwani, & Fortenberry, 2015; Pettifor et al.,
2013). Additionally, there is limited HIV prevention awareness among the target
population relative to the effectiveness of comprehensive HIV prevention strategies that
integrate behavioral, structural, and biological factors (Firestone et al., 2014; Pettifor et
al, 2013). Minority MSM failure to use healthcare was attributed to access issues relative
to lack of insurance or being underinsured, transportation barriers, stigma, and
engendered mistrust (Eaton et al., 2015). Additionally, there is limited research
supporting engagement in care outcomes for minority MSM and how missed clinical
appointments may contribute to ART initiation, viral suppression, or their survival.
Young adult MSM HIV treatment and management involves ART, issues relative
to long-term adverse medication reactions, and a sense of disinhibition following ART
initiation, adherence, and resistance (Machimba et al., 2013; Pandhi & Ailawadi, 2014).
Disinhibition includes impulsive behaviors, externalization or destructiveness, illegal
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drug use, and poor risk assessment and contribute to adolescents’ risky sexual behaviors
(Machimba et al., 2013).
ART adherence plays an essential role in regulating viral replication, preserving
health and decreasing viral transmission; however, globally, there is inadequate data
regarding adherence among adolescents and young adults, especially in the MSM
population (Hightow-Weidman et al., 2017; Kim et al, 2014). Exploration of the research
topic could help to fill the gap between ART adherence among adolescents and young
adults and the MSM population, as it may assist in gaining knowledge about factors that
contribute to youth’s nonadherence to ART and provide insights relative to the
significance of creating young adult-centered prevention strategies within a socialeconomic context for key populations such as MSM. Additionally, the results of this
research may contribute to reductions in not only current rates of HIV infection but also
deaths among this population. Adherence to the treatment regimen is critically important
to sustain HIV suppression and decrease the risk of medication resistance and results in a
better quality of health and life and reduces HIV transmission and mortality (National
Institutes of Health [NIH], 2018).
Purpose
The purpose of this quantitative cross-sectional study is to identify factors that
influence adherence to ART among young MSM whose HIV status is positive. This will
be accomplished by investigating the relationship between the independent variables
ART insurance coverage, engagement in care, and viral load suppression and the
dependent variable ART adherence as measured by dose, schedule, and instructions.
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Additionally, determinants such as age, ethnicity, income, and educational attainment that
may contribute to ART nonadherence in the study population will be examined.
Considering that MSM are a key population with the highest rates of newly diagnosed
HIV within the United States (CDC, 2018), the proposed research has the potential to
contribute to literature because there is limited research on the association between
factors that could influence young HIV+ MSM adherence to ART.
Research Questions and Hypotheses
The following research questions will be addressed:
RQ1: Is there a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia?
H01: There is no relationship between awareness about ART and adherence to
ART among young HIV+ MSM between the ages of 18 and 39 in Georgia.
H01: There is a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ2: Is there an association between age, ethnicity, educational attainment,
income, and ART insurance coverage and adherence to ART among young HIV+ MSM
between the ages of 18 and 39 in Georgia?
H02: There is no association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
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Ha2: There is an association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ3: Is there is a relationship between engagement in care, viral load
suppression, and adherence to ART among young HIV+ MSM between the ages of 18
and 39 in Georgia?
H03: There is no relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Ha3: There is a relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Theoretical Foundation for the Study
The social cognitive theory (SCT) is the theoretical framework that I will use to
direct and support the research study. The theory posits knowledge occurs through social
context with a dynamic and mutual interface between the person, environment, and
behavior (Glanz, Rimer, & Viswanath, 2015). The theory has been used as an invaluable
public health tool in health promotion, especially among youth and provides an essential
foundation for understanding the development of human behavior. The SCT is related to
the initiation and attainment of personal and group-level changes and maintenance of
health-related behavior modifications and relapse prevention, which is essential to

8
medication adherence in youth (Glanz et al., 2015). A central concept of the SCT is
reciprocal determinism. A central concept of the SCT is reciprocal determinism.
According to Adefolalu (2018), reciprocal determinism refers to the dynamic interaction
of the triadic influences between an individual's behavior, personal factors, and the
environment. In this regard, the construct of reciprocal determinism will be used to
address personal determinants of health (age, ethnicity, educational attainment, income,
and ART insurance coverage), which constantly influences the other. These social
environmental factors influence both personal and behavioral factors such as young
MSM’s capacity to adhere to ART.

Figure 1. Link between SCT theory constructs and study variables.
Nature of the Study
The proposed study is quantitative in nature and based on a secondary analysis of
cross-sectional survey data. Secondary data will be obtained from the Georgia Medical
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Monitoring Project (GMMP) surveillance summary. The MMP is a CDC-funded
surveillance project that produces data on persons living with HIV in Georgia. This data
was selected because it contained information relative to the variables of interest and the
MSM population. The quantitative design was used because it will assist in determining
if there is an association between the independent and dependent variables. Additionally,
the quantitative design will allow me to use measurable data to discuss facts about the
research findings and reveal any patterns in the study. The cross-sectional study design
will also assist in determining if an association exist among the identified variables.
Independent Variables
The Georgia Department of Public Health [GDPH] stated Age is defined as the
chronological age of the research participant at the time of the interview in terms of years
and ethnicity is defined as race. Participant incomes represent the combined yearly
household income in U.S. dollars, which ranges from $0 to > $75,000 (GDPH, 2015;
Assistant Secretary for Planning and Evaluation, 2018). Educational attainment is the
highest level of education an individual has completed (National Center for Educational
Statistics [NCES], 2018). Health insurance and other ART coverage are terms used to
categorize resources used to provide coverage for ART medications 12 months prior to
being interviewed for the Georgia MMP (GDPH, 2015). The GDPH (2015) stated
engagement in care refers to primary HIV healthcare, which is measured by participants’
use of healthcare services, the number of viral load tests obtained within a 6-month
period, and receipt of at least one cluster of differentiation 4 (CD4) tests annually
(GDPH, 2015). The CD4 test measures the number of white blood cells that fight
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infection and play an important role in a person’s immune system. Replication of the HIV
virus within an individual’s body is commonly referred to as the viral load.
Dependent Variable
ART medication adherence refers to following a specific dose, set of pills, spoonful, or
injections of ART medications according to a prescribed schedule or special instructions
(GDPH, 2015). The SCT framework will be used to support and direct this research.
Specifically, the behavioral change constructs embedded within the SCT will be used
because they could help explain factors that influence young HIV+ MSM adherence to
ART (Adefolalu, 2018). Further, to examine the relationship between the variables that
influence young HIV+ MSM adherence to ART, statistical analysis will be conducted
using data obtained from the Georgia MMP surveillance summary about the target
population’s health behaviors. Descriptive and inferential statistical analysis will be
conducted on the approved dataset using Statistical Package for Social Sciences (SPSS)
software. Inferential statistical tests may include correlations, regression, and analysis of
variance.
Literature Search Strategy
To examine the relationship between social determinants, engagement in care,
viral load suppression, and ART adherence among the study population, multiple
electronic databases were accessed. Research used to support the study were published
between 2014 and 2019. The specific databases included Google Scholar, Google,
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Academic Journals, PubMed, ProQuest, Cumulative Index to Nursing, Science Direct,
Allied Health Literature (CINAHL), and EBSCOHost.
The following are key search terms used for literature search strategy: Human
Immunodeficiency Virus (HIV), adolescents, youth, young adults, MSM, viral load
suppression, clusters of differentiation 4 (CD4), antiretroviral therapy, prep-exposure
prophylaxis, medication adherence, HIV awareness, social determinants, engagement in
care, antiretroviral insurance coverage, educational attainment, social cognitive theory,
transtheoretical model, reciprocal determination, disinhibition, Affordable Care Act, peer
pressure, youth developmental stages and associated challenges, barriers to ART
adherence, HIV vulnerability, HIV care continuum, retention in care, insurance programs
for HIV care, The Boolean operator AND was used to combine and broaden the research
terms.
Literature Review Related to Key Variables and/or Concepts
ART Adherence
The introduction of ART medications or therapy changed the devastating impact
of the HIV pandemic on population health nationally and globally and prevented deaths
in greater than 80 million (Iacob et al., 2017). The development of these advanced
treatments has altered the landscape of HIV from a death sentence to a curable chronic
disease (Iacob et al., 2017). ART adherence is essential to optimal management and
treatment of HIV; however, its efficacy is contingent upon individual medication
adherence (Yang et al., 2018). While precise levels of adherence required to reduce
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mortality, drug resistance, and viral rebound differ based on the medication and treatment
regimen, increasing levels of adherence to ART, as evident by viral load suppression
rates are associated with improved health outcomes (Puskas, 2017).
Morrison, Stauffer, and& Kaufman (2015) said adherence is the ratio between the
numbers of medication dosages taken and the amount prescribed over a period.
Chakrabarti (2014) defined adherence as a process by which a proper treatment regimen
is prescribed by a clinical provider after engaging in an appropriate conversation with the
patient. Medication adherence is a significant behavior that is necessary over one’s
lifespan for prevention and management of disease and the preservation of health
(Molloy & Carrol, 2017). Medication adherence is important to sustaining HIV
suppression and decreasing the risk of medication resistance, when practiced routinely
adherence results in a better quality of health and life, and reduces HIV transmission and
mortality (NIH, 2018). The literature is saturated with studies concerning the significance
of medication adherence, especially relative to ART adherence in individuals living with
HIV and AIDS. C. Everett Coop, former U.S. Surgeon General, stated medications do
not work in individuals who do not take them (Lindenfeld, 2017). In this regard, it is
important to understand the challenges of maintaining adherence to ART and the clinical
implications of nonadherence in adolescents and young adults infected with HIV because
42% to 80% of these individuals report suboptimal adherence to ART (Voisin et al.,
2017).
Among individuals within the U.S., the prevalence of HIV/AIDS
disproportionally affects young adults, racial and ethnic minority groups, and MSM at
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rates higher than other demographic groups (Gross, Hosek, Richards, & Ferandez, 2016).
Young adults experience distinct challenges with medication adherence secondary to
their developmental stage. These challenges may include lack of fiscal resources, lack of
privacy at school for medication administration, and having to take multiple medications.
Additionally, the adolescent developmental stage is a conundrum of mental, physical and
emotional maturation; it is a challenging crossroads (Kim, Gerver, Fidler & Ward, 2014;
NIH, 2018). The developmental stage of adolescence is a period where young adults are
striving for their independence, fixate on themselves and their self-image, need peer
approval and support, engage in risk-taking behaviors, and have evolving decisional
capacities (NIH, 2018). Kim et al. (2014) said adolescence and young adulthood is a
period of identity formation, indulgence in behavioral experimentation, engagement in
high-risk sexual behaviors, alcohol, and drug use, limited life skills and knowledge, lack
of fiscal autonomy, and resistance to engagement in medical care.
ART adherence is a critical component of the HIV treatment cascade and care
continuum, a framework established in 2013 which is comprised of five primary stages:
diagnosis, linkage to care, retention in care, ART adherence, and viral suppression (Kay,
Batey, & Mugavero, 2016). To achieve optimal outcomes from HIV treatments,
exceptional adherence (>95%) to ART is necessary, as it preserves the functionality of
the immune system (Coetzee, Kagee, & Bland, 2015; Govind et al., 2017). The immune
system weakens when CD4 counts are reduced and increases the risk for opportunistic
infections as well as non-AIDS and AIDS-related diseases secondary to prolonged
inflammation (Coetzee et al., 2015; NIH, 2019).
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Characteristics: Young Adult MSM Versus Adult MSM & ART
Diverse individual factors within a population are associated with suboptimal
ART adherence among MSM (Iacob et al., 2017). General factors relative to MSM
suboptimal adherence include the complexity of the medication regimen, side effects of
ART, individual behaviors, use of illegal drugs and alcohol, depression, and other
diseases or comorbidities germane to each individual person (Iacob et al., 2017). Stigma
and lack of disclosure about HIV status were found to be challenges associated with
MSM adherence to ART and were consistent with all HIV populations. Issues relevant to
young MSM included stigma-induced economic and social issues, challenging
relationships with healthcare providers, community-based and clinical care associated
discrimination, and the lack of availability of MSM-friendly clinical services (Michen et
al., 2017). Iacob et al. (2017) found that young MSM ART nonadherence was attributed
to stigma, depression/anxiety, fear of inadvertent disclosure, social isolation, lack of
social support and participation in criminal or inappropriate social groups, limited
communication skills and education, lack of motivation, logistical barriers, overlooking
medication doses, and inconsistencies in routine and travel (Iacob et al., 2017; Zanoni &
Mayer, 2014). Adult MSMs experience challenges consistent with young MSM which
include stigma, social isolation, and barriers to accessing healthcare programs (Iacob et
al., 2017). Iacob et al. (2017) said fear of engagement and rejection of care and the lack
of availability of data regarding ART interactions and hormonal treatment (for
individuals using hormones) were germane to adult MSM.
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Among young African American HIV+ MSM, factors that contributed to
suboptimal ART adherence were consistent with Iacob et al. (2017) study findings;
however, Voisin et al. (2017) study results found that low self-efficacy and exposure to
community violence where additional factors that contributed to suboptimal ART
adherence. Alcohol (OR: .150, 95% CI: .037–.606) and marijuana usage (OR: .235, 95%
CI: .066–.832) were indicative of poor adherence to ART among African Americans as
well (Voisin et al., 2017). Alcohol and marijuana are commonly used as coping
techniques for HIV diagnosis and may hinder engagement in care (Voisin et., 2017).
Further, substance usage is a barrier for not only engagement or initiation in care but also
medication management skills, and on occasion can result in depression (Voisin et al.,
2017). Among racial and ethnic MSM minority groups, self-efficacy was the strongest
predictor of ART adherence (Voisin et al., 2017).
Medication adherence in HIV+ individuals does not correlate with traditional
findings in the literature for medication adherence. Traditionally, elderly adults and
children are at greater risk for medication nonadherence due to factors such as medication
complexity, side effects, socioeconomic factors, mistrust of healthcare providers, and
healthcare systems, and cognitive decline (Frances, Thirumoorthy, & Kwan, 2016). A
young person’s age serves a potential contributor to their nonadherence secondary to their
limited knowledge and understanding about the disease or treatment, family structure,
culture, fiscal status, medication regimen and at times, the medication’s taste (El-Rachidi,
LaRochelle, & Morgan, 2017). Additionally, the young may be dependent on their
parents and other social support to assist with their medication adherence (Kay et al.,
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2016). According to Adefolalu (2018), the SCT is relevant to the management and
treatment of chronic diseases because it may assist individuals with learning pertinent
information about HIV and AIDS and the necessary steps they need to take regarding
their disease and the related health issues such as ART adherence and the establishment
of supportive relationships.
Social Determinants
Social determinants of health (SDOH) are factors that influence a person’s state of
health and disease and shape an individual’s health, functioning, and quality of life
outcomes and risks (Artiga & Hinton, 2018; Healthy People 2020, 2018a). These
conditions are formed by the dissemination of resources, money, and power at the global,
national, and local levels (World Health Organization [WHO], 2018a). Additionally,
SDOH are responsible for health inequities, which are biased and preventable differences
in health status evident within and between countries (WHO, 2018a). These determinants
are the primary cause of health disparities throughout the lifecycle and profoundly
influence the development of young adults and contribute to the social modeling of
health, disease, and illness (CDC, 2014; Tebb, Pica, Twietmeyer, Diaz, & Brindis, 2017).
SDOH are dynamic in nature and may be biological (age), individual (unprotected sex),
social (income, gender), and physical environment (living conditions) and health (access
to healthcare) factors that interact with and influence individual behaviors (CDC, 2014).
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ART and Other Insurance Coverage
The ability to obtain and access healthcare and the quality of care received are
significant determinants of health (Ludema et al., 2017). According to Sommers et al.
(2017), evaluating the effect of insurance coverage on health is multifaceted because its
impact occurs over an extended period, varies based on the insurance design, and may be
misinterpreted based on confounding factors, since insurance changes are associated with
other issues that influence healthcare usage and outcomes. In 2011, there were 30,400
uninsured individuals who died annually due to a lack of insurance (Powell & Xirasagar,
2017). Lack of insurance served as a proxy for risk factors such as individual health
behavior or socioeconomic status contributed to premature death (Sommers et al., 2017).
Absence of health insurance serves as a barrier to medical care and contributes to poorer
health outcomes, as the uninsured do not readily seek out timely care (Sommers et al.,
2017). Insurance is an instrument that improves fiscal security and decreases risks for
large unpredictable medical costs, increases access to preventive services, which can
directly maintain or improve health, enhances self-perceptions of health, and is important
for individuals with chronic diseases such as HIV (Sommers et al., 2017). Further, the
availability of insurance affects all stages of the HIV continuum of care including HIV
diagnosis, linkage and retention in care, and prescribing of ART through viral
suppression (Kay et al., 2017).
Young adults with chronic diseases such as HIV/AIDS are at 50% higher risk for
being uninsured and have 33% lower rates of health insurance coverage than any other
age group (Coetzee et al., 2015; Spencer et al., 2018; U.S. Census, 2018a). Likewise, in
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2015, individuals infected with HIV had an uninsured rate of 11% compared to an
uninsured rate of 13% in individuals who are uninfected (Dawson & Kates, 2019; Zanoni
& Mayers, 2014). The availability of health insurance or medication coverage is
significant in maintaining ART adherence and preserving life among young adults
(Mizuno, Beer, Huang, & Frazier, 2017).
Prior to the Affordable Care Act (ACA), minority, racial/ethnic groups were
disproportionately affected by HIV, underprivileged, and uninsured (Ludema et al.,
2017). The expansion of the ACA resulted in better health outcomes, greater access to
primary care, increased ambulatory care visits, improved use of prescription medications,
and enhanced medication adherence (Ludema et al., 2017). As it relates to young adults,
the ACA facilitated greater access to care, as one of its tenets required insurers to allowed
family members to remain on parental private insurances until they were 26 years of age
(McMorrow, Kenney, Long & Anderson, 2015). For young adults with higher incomes,
the ACA contributed to reductions in the number of uninsured; however, among those
with lower and modest incomes, there were substantial reductions (49%) in the number of
uninsured, especially in states with Medicaid expansion compared to 27% in
nonexpansion states (Chaudry, Jackson, & Glied, 2019; McMorrow et al., 2015).
The ACA eliminated barriers to care for HIV/AIDS-infected individuals because
it prevented the denial of health insurance based on preexisting health conditions, which
historically served as an obstacle to obtaining or being dropped from coverage (U.S.
Department of Health and Human Services [DHHS], n.d.). Additionally, the ACA
established essential health benefits which establish a minimum set of benefits that must
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be provided under an insurance plan (DHHS, n.d.). The benefits include prescription
medication services for chronic diseases, mental health and substance use disorder
services, as well as inpatient hospitalization and laboratory testing, essentially ensuring
comprehensive primary, urgent, and emergent healthcare is available to everyone
(DHHS, n.d.). Despite the benefits inherent in the ACA, Spencer (2018) asserted there is
an age gradient between adolescents that revealed worse health insurance coverage and
access for younger and older adolescents, peaking among young adults. Further, as youth
transition into adult care, they may experience challenges relative to continuity of care
and the type of insurance available to them, which may negatively influence access to
care and ultimately ART adherence (Spencer, 2018).
Medicaid
The U.S. Medicaid program provides health insurance to individuals with low
incomes. The program is a federal-state partnership which allows each state and territory
to implement their own Medicaid program in compliance with wide-ranging federal
guidelines (Zhang et al., 2015). In addition to being the largest public health insurance
program in the nation, Medicaid provides healthcare coverage to 50% of all people with
HIV in the U.S. (Zhang et al., 2015). From 2012 to 2014 (Kates & Dawson, 2017), HIVinfected individuals residing in non-Medicaid expansion states did not realize a
significant increase in coverage; however, there was a significant increase in dependence
on the Ryan White HIV/AIDS federal programs through the Health Resources and
Services Administration (HRSA) which provided state-based funding in support of HIV
care which consists of the AIDS Drug Assistance Program (ADAP).
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Ryan White Program
According to Lunden et. al., (2017), ADAP provides HIV prescription drug
coverage to individuals with limited to no fiscal resources. The researchers found that
health insurance coupled with prescription drug coverage resulted in greater usage of
ART among all HIV-infected groups.
As the Ryan White law is currently written, all individuals receiving ADAP must
be HIV-positive, low-income, and underinsured or uninsured and the services must be
equally and constantly available to all eligible participants throughout a state (HRSA,
2017). ADAPs may also assist in linking individuals to other care and support services.
As an example, ADAP funds may be utilized to secure health insurance for services that
improve access to care, ART adherence and monitoring of ART drug treatments (HRSA,
2017). ADAP eligibility is contingent upon state-based requirements and participants in
the program must provide evidence to support their state residency status and meet the
fiscal requirements that are based on the Federal Poverty Level guidelines (HRSA, 2017).
Private Insurance
Treatment benefits covered via private insurance is contingent upon the state’s
insurance laws. Historically, private insurances required applicants to be prescreened for
pre-existing chronic health diseases or health risk prior to offering the individual
insurance (Spencer et al., 2018). Insurance premiums varied based on the identified
disease or associated health risk (Spencer et al., 2018). Additionally, there were limits on
benefits and out-of-pocket expenses were costly (Kates & Dawson, 2017; Spencer et al.,
2018). Privately insured HIV+ individuals experienced challenges maintaining their
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health secondary to the cost relative to premiums, co-pays, deductibles, and costs of
services, such as specialty care, that was not covered by insurance policies (Kates &
Dawson, 2017; Spencer et al., 2018). Often times, private insurance policies had limits on
services needed by those with HIV/AIDS such as case management, substance abuse and
mental health abuse, transportation assistance and specialty care (Spencer et al., 2018).
The ACA’s tenants have abated many of the historical barriers to care HIV infected
individual’s experienced (Kate & Dawson, 2017). The ACA played a critical part in
increasing insurance coverage for HIV infected individuals through Medicaid expansion,
despite that fact that not all states participated in the expansion (Kate & Dawson, 2017).
Race/Ethnicity
According to Khahana et al. (2016), among HIV+ cohorts within the U.S.,
minority racial/ethnic groups experienced the lowest levels of ART adherence and viral
load suppression even after controlling for confounding factors such as demographics,
mental health and substance use. Across the U.S. racial/ethnic variances in viral load
suppression existed across all age, sex, and transmission classes with the lowest incidence
of sustained viral suppression being among young African Americans, 13 to 24 years of
age (Crepaz, Dong, Wang & Hernandez, 2018). Multiple barriers such as culture, being
uninsured, access to care issues, health literacy, stigma, issues relative to trust in the
health care system and providers were attributes that resulted in the lower incidence of
sustained viral load suppression among African Americans (Crepaz et al., 2018).
Additionally, these health care disparities may partially be secondary to a late diagnosis
of HIV infection and poor adherence to ART therapy as well as racial/ethnic-based
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medical mistrust, which is a significant predictor of ART nonadherence among people
who are HIV+ (Kalichman, 2016). Beer et al. (2016) asserted while racial/ethnic
disparities remain across all populations when analyzing ART prescriptions and viral
suppression among HIV-infected persons in care, disparities among MSM were not
found.
Educational Attainment
Educational attainment is a social determinant that influences diverse aspects of
life and is the most significant modifiable social determinant of health (McGill, 2016).
The quality and length of education is a predictor of employment and income and affects
whether a person can afford health care and increases an individual’s potential for future
well-being (McGill, 2016). Additionally, low education attainment is associated with
more stress and lower self-confidence (WHO, 2018b). Health threats connected with
social determinants create barriers that prohibited people from achieving optimal health
(Stahre et al., 2015). According to the U.S. Census Bureau (2018b), in 2017, 80 percent
of African Americans over the age of 25 completed high school and received their
diploma; however, the numbers are 10 percentage points lower than the national average.
Additionally, in 2017, 23.9 percent of African American adults received a bachelor’s
degree or higher, which is substantially higher than 19.8 percent in 2010. Despite these
increases, there continues to be a racial gap relative to educational attainment among
African Americans, especially males. Individuals who are HIV+ with lower educational
attainment experienced worse health outcomes after initiating ART therapy including
higher rates of new AIDS events and mortality (del Amo et al., 2017). Stevens et al.
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(2017) found that MSM who did not finish high school were more likely to engage in
transactional sex, which heightened their risk for HIV infection. Solomon et al. (2018)
said individuals with higher educational attainment initiated ART after being newly
diagnosed with the HIV infection. Information relative to the timing of initiation was not
provided. Younger MSM, individuals 19 years of age and less who did not complete
high school) were not as likely to receive HIV testing as those who completed high
school (Solomon et al., 2018).
Income
According to Braveman and Gottlieb (2014), socioeconomic dynamics inclusive
of income, wealth, and education are fundamental reasons for an array of health
outcomes. The socioeconomic dynamics play a prevailing role for social factors instead
of medical care in shaping health through diverse health indicators, settings, and
populations (Braveman & Gottieb, 2014). Higher income is associated with being
healthier (WHO, 2018b). More specifically, the larger the gap between the affluent and
underprivileged, the larger the differences in health (WHO, 2018b). Chokshi and Cohen
(2018) stated race, sex and educational attainment act together and confounds the
income-health relationship.
Among HIV-infected individuals, unemployment and limited access to fiscal
resources have been associated with suboptimal ART adherence (Nachega et al., 2015).
ART adherence was higher in HIV+ individuals who were gainfully employed compared
to those who were not, especially those in low- and high-income countries (Nachega et
al., 2015). ART nonadherence was related to the adverse effects unemployment had on an
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individual’s mental health, depression and compromised psychosocial health (Nachega et
al., 2015). Additionally, unemployment, lack of income and poverty contributed to food
insecurity, barriers to transportation and access to health care, which are implicated in
suboptimal ART adherence in young adults (Ammona, Mason, & Corkery, 2018; Azia,
Mukumbang, & Van Wyk, 2016).
Employment and the availability of fiscal resources are critical to maintaining
optimal adherence to ART. Employment has the potential to mitigate contextual barriers
to ART adherence by promoting greater access to health care services secondary to the
availability of employer-based insurance and health care programs that encourage
engagement in HIV treatment (Azia, Mukumbang, & Van Wyk, 2016; Nachega et al.,
2015). Employment may eliminate food insecurity, improve housing quality and facilitate
reductions in poverty, which may positively influence the quality of life of young adults
infected with HIV (Nachega et al., 2015).
HIV infection among MSM is a complex array of diverse factors operating at
different levels (Gourlay et al., 2017). In this regard, obtaining a comprehensive
understanding of factors that influence medication adherence from as social and
environmental context is essential for the development of multi-level strategies to reduce
the risk of HIV acquisition among high-risk MSM (Gourlay et al., 2017). Understanding
contextual factors associated with young adults’ progression through the HIV care
continuum connects to the SCT constructs and reciprocal determinism in learning
behaviors that are supportive of ART medication adherence. The SCT may be used to
assist patients with chronic illnesses such as HIV by providing them relevant information
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about HIV and AIDS and the potential actions to take in making decisions about the
disease and its associated health challenges such as adherence (Adefolalu, 2018).
Linkage to Care
To mitigate disease advancement and continuous transmission of HIV, young
MSM who are HIV+ must be effectively linked to timely health care (Zanoni & Mayer,
2014). Effective linkage of HIV+ MSM to care is significant because connectivity to and
engagement are the primary bridge to obtaining the health and preventative benefits of
ART (Iacob et al., 2017). Numerous studies revealed young individuals who are HIV+
have lower rates of linkage to HIV care (29% to 73%) within the first year of diagnosis
than other groups (Zanoni & Mayer, 2014). In 2014, approximately 62% of young HIV+
individuals in the U.S. linked to care within 6 to 12 months (Zanoni & Mayer, 2014).
Barriers that may contribute to suboptimal linkage to care are: (a) perceived
discriminatory practices by clinical providers, (b) deficient medical guidance and
continuation in care, (c) clinic operational hours or location are not easy to access, (d)
concerns with disclosure of HIV diagnosis, (e) psychological challenges associated with
obligating to long-term care and (f) concerns relative to HIV treatment include
medication side effects, inadequate information and understanding of the benefits of ART
and the scheduling of medications at inconvenient times (Liu et al, 2016).
Engagement in Care
Engagement in care is an integral part of the HIV continuum and refers to a
traditional source for primary HIV health care (GDPH, 2015; Sabin et al., 2017). The first
stage of engagement in care occurs when HIV+ individuals are linked to care or
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completes their initial medical appointment within 30 days after diagnosis (Dombrowski
& Kinney, 2017). Philbin et al. (2014) described linkage to care as a process whereby
newly diagnosed HIV+ individuals initiate HIV-related medical, psychological and social
services. Philbin et al. (2014) asserted engagement in care is the maintenance of HIVrelated health care that requires adherence to clinical appointments for three to six
months.
Young adult African American MSM do not obtain timely medical treatment or
engage in care, which increases their HIV transmission rates because upon entering into
care, they are found to have an advanced stage of HIV disease (Dombrowski & Kinney,
2017). This is significant because engagement in the HIV care continuum is an essential
precursor to retention in care, initiation of ART and viral suppression, thus crucial in
maximizing the effects of ART globally (Dombrowski & Kinney, 2017; Genberg et al.,
2016). Numerous barriers may negatively influence engagement in HIV care, limiting
the efficiency of strategies aimed at improving health outcomes and reducing new HIV
transmissions (DHHS, 2016). Similarly, there are diverse factors that positively influence
or facilitate engagement in HIV care (Yehia et al., 2015).
Barriers to Care
Linkage, engagement, and retention in HIV care are essential to sustaining life
and reducing the risk of HIV transmission (Genberg et al., 2016). HIV+ African
American MSM who do not engage in care experience higher morbidity and greater
mortality than those in care (Eaton et al., 2015). Deterrents to care are multifactorial and
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may include sociodemographic, clinical, and personal characteristics (Liu et al., 2016;
Yehia et al., 2015).
Distance from Clinic
Dasgupta et al. (2015) asserted, within the US, travel-related obstacles contributed
to delays in MSM receiving primary HIV care. More specifically, the distance and
amount of time traveled as well as the mode of transportation were associated with
considerable obstacles to engagement in care (Dasgupta et al., 2015; Liu et al., 2016;
Sharma, Barnabas, & Celum, 2017). Accessibility to public transportation, a personal
means of transportation, and the amount of traffic encountered was contingent upon an
individual’s neighborhood and served as a significant predictor of commute time and
subsequent poor engagement in care (Dasgupta et al., 2015). Further, public
transportation via a bus or train compared to private/personal transportation served as an
obstacle to care (Dasgupta et al., 2015). Other obstacles associated with the distance
from the clinical site that contributed to suboptimal engagement in care included regional
differences in home locations and the availability of providers within close proximity
(Dasgupta et al., 2015; Liu et al., 2016). Liu et al. (2016) found that the inflexibility of
work schedules (9 a.m. to 5:00 p.m.) and the operational hours for medical services
(Monday – Friday from 8:30 a.m. to 5:30 p.m.) resulted in challenges relative to the
distance traveled. The inflexibility of clinical hours and job schedules did not allow
enough time for patients to arrive timely to their appointment (Lieu et al., 2016).
Hightow-Wideman et al. (2017) asserted, among young African American HIV+ MSM,
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transportation challenges and an inconvenient location for clinical services were the most
common contributor to suboptimal engagement in care.
Stigma and Discriminatory Practices
Lieu et al. (2016) found that MSM reluctance to engage in HIV care is
significantly associated with stigma and discrimination. Additionally, MSM experience
suboptimal engagement in care due to fear of the possibility of encountering non-gay
acquaintances in the hospital and other clinical settings (Liu et al., 2016). Obtaining a
comprehensive understanding of how stigma and discriminatory practices related to HIV
acquisition and transmission among MSM is a life-threatening public health challenge
(Frye et al., 2015). Discriminatory experiences may increase HIV infection among MSM
(Frye et al., 2015). Members of stigmatized groups encounter chronic stress and social
discrimination associated with perceptions about their sexual orientation or gender
identity (Frye et al., 2015). Minority MSM who experience race and sexual
discrimination are at greater risk for HIV infection secondary to engagement in risky
sexual behaviors, which may be related to depression and substance or alcohol use (Frye
et al., 2015). Eaton et al. (2015) found that whether HIV+ or not, MSM experience
stigma from health care providers that they felt were associated with their sexual
orientation, medical mistrust and racism. In fact, healthcare-related stigma was
significantly associated with prolonged delays in African American MSM receiving
medical care and negatively influenced engagement in preventative services, health care
access, and patient-provider communications (Eaton et al., 2015; Hightow-Weidman et
al., 2017).
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Fear of disclosure or being seen in an HIV-related health facility contributed to
poor engagement in care (Ogunbajo, 2017). Young MSM delay or avoided HIV testing
and engaging in HIV healthcare due to fear that medical providers may be judgmental
about their sexual practices, reveal their HIV status or violate their right to privacy and
share information about their sexual preferences with parents or other family members
(Liu et al., 2016; Fisher, Fried, Macapagal & Mustanskic, 2016). MSM also delay or
avoid engagement in care because of anxiety related to documentation that supports an
HIV diagnosis and treatment, which may subsequently be connected to their medical
record thus potentially influencing their eligibility for future health insurance coverage or
fear that the information may be reported to governmental organizations (Liu et al, 2016).
Behaviors or Attitudes among Clinical Providers
Given the stigmatization and negative attitudes MSM experienced with clinical
providers, within the U.S., disclosure rates ranged from 49% to 70% and serve as a
barrier to engagement in HIV care (Qia, Zhou, & Li, 2018; Quinn et al, 2017). MSM
disclosure plays a significant role in engagement in care and results in greater health-care
utilization, a healthier perception of health status, and lower rates of depression (Qia et
al., 2018). There is a positive association between sexual behavior/identity disclosure and
engagement in the HIV care continuum (Qia et al., 2018; Quinn et al., 2017).
Medical mistrust negatively influences MSM disclosure and a clinical provider’s
ability to engage them and meet their medical needs (Eaton et al., 2017). The lack of
trust in clinical providers may create concerns regarding violation of privacy, fear of
being denied health care, and being stigmatized by the clinical provider (Quinn et al.,

30
2017). Quinn et al. (2018) found that among young African American MSM, regardless
of the type of stigma experienced, there was a differential effect on their health and
psychosocial outcomes, which suggested, HIV stigma has the potential to affect
significantly viral suppression and medication adherence among this group.
Personal Factors
Age
Age is a biological social determinant of health that may influence the health
outcomes of specific populations greater than others such as young MSM (Healthy
People 2020, 2018a). Adolescents and young adults within the United States have poorer
retention in care, a bigger delay in the initiation of ART, and poorer rates of viral
suppression compared to older adults (Shaw & Amico, 2016). ART adherence is a
significant challenge among young MSM secondary to their developmental state
(McCarthy et al., 2018). Developmentally, young adulthood may be described as a stage
whereby individuals experience less inhibition, a carefree demeanor and participate in
risk-taking such as unprotected sexual activities, are spontaneous and do not engage in
effective planning, and generally are not monitored as closely by their parents (Whiteley,
Brown, Lally, Heck, & van den Berg, 2018). Young adults may feel like they are
invulnerable; therefore, invincible to the consequences of their actions, which may
explain the risk-taking and limit-testing behaviors seen during this developmental state
(Whiteley et al., 2018). The aforementioned characteristics may contribute to lower rates
of adherence to care among this age group, which may include engagement in HIV
prevention strategies, the HIV continuum, and ART adherence (Whiteley et al., 2018).
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Enhanced ART adherence resulting in sustained viral suppression within this population
is vital to decreasing HIV transmission rates, poor health outcomes, increased
hospitalizations and death (Hanna, Miller, Foster & Russell, 2014; Shaw & Amico, 2016;
Lacey).
Ethnicity
Hussen, Harper, Bauermeister and Hightow-Weidman (2015) posited being
young, African American, and gay may have an independent and interdependent
relationship with the probability of suboptimal engagement at various stages of the HIV
care continuum. Young HIV individuals are constantly at the highest risk for suboptimal
and non-engagement in care at each stage of the continuum (Hussen et al., 2015).
Personal or individual factors contribute to this suboptimal engagement in care (Zhang et
al., 2015). Personal factors may include psychological and psychosocial issues such as
depression, negative self-image, substance or alcohol use, stress, medication side effects
and feelings of compromised masculinity due to fear of pursuing health care (Zhang et al,
2015; Hussen et al., 2015). Other personal factors may include cognitive processes such
as self-efficacy, motivational readiness, and optimism regarding the benefits of ART and
social support (Gross et al., 2016). Hussen et al. (2015) found that MSM identity and
ethnic identity were associated with adherence to health care appointments, while there
was limited evidence supporting the role of HIV+ identity. Among young adults,
specifically African American males, cognitive belief systems such as self-efficacy,
motivational readiness, and decisional imbalance; psychological distress, which includes
anxiety, suicidal ideation and depression; and substance and alcohol use were the most
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reliable personal attributes meaningfully associated with a young adult’s conduct
regarding ART adherence (Gross et al., 2016).
Facilitators of Care
Facilitators to HIV care play a significant role throughout the HIV care continuum
(Grau et al., 2017). Facilitators are strategies that encourage HIV+ individuals to engage
in care to maximize the effectiveness of ART (Genberg et al., 2016). Consistent with
barriers to HIV care, facilitators of care are multifaceted and may include social support,
positive experience in a healthcare setting and rapport with personnel, health insurance,
and an integrated model of care (Ogunbajo et al.; GDPH, 2017).
Social Support
Matsumoto et al. (2017) posited social support is a multidimensional concept that
plays an essential role in positive health outcomes and well-being. There are four primary
types of social support: (a) emotional support, which may include empathy and
expressions of care and trust; (b) informational support such as advice, informational
materials, and recommendations; (c) tangible support such as financial support or
everyday hands-on assistance; and (d) positive social companionship, which may include
friends, family, neighbors and disease-specific groups (Cook, Canidate, Ennis, & Cook,
2018; Matsumoto et al., 2017). According to Iacob et al. (2017), social and emotional
support from HIV support groups is also essential in HIV care and ART adherence.
Voisin et al. (2017) suggested young adults with a high amount of social support tend to
have higher self-efficacy, which contributes to better motivational readiness for ART
adherence. Voisin et al. (2017) also found when analyzing the association between
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familial or friends support related to medication reminders and optimal ART adherence,
there was not a relationship. However, a family’s acceptance of the HIV diagnosis was
associated with optimal adherence. Engagement in HIV specific support group events is
also associated with higher rates of ART adherence than those who do not participate
(Tumwikirize, Torpey, Adedokun, & Badru, 2015).
Among individuals with increased stress levels related to chronic health
conditions similar to HIV/AIDS, social support promoted psychological changes while
the perception of social support was associated with their physical and mental health
(Tumwikirize et al., 2015). Despite the evidence supporting the value of support groups
in ART adherence, the literature suggested, young HIV+ individuals do not participate in
them due to stigma, fear of disclosure and lack of youth-friendly clinical services (; Iacob
et al., 2017; Tumwikirize et al., 2015).
Integrated Model of Care and Specialty Care Integration
An integrated model of care allows individuals living with HIV/AIDS to be
involved in all facets of their health care (GDPH, 2017). Establishing an integrated
model fosters a framework that promotes cultural and linguistically appropriate services,
which may improve efforts to address health care disparities (GDPH, 2017).
Additionally, integrating primary care with specialty care such as mental/behavioral
health care and HIV care has reduced patient wait times, enhanced coordination of care,
and facilitated more efficient and comprehensive delivery of services (Bernard, Tailor,
Jones & Alexander, 2016). Designing collaborative and integrated service is significant
because according to the Institute of Medicine, due to the complexity of the health care
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challenges associated with HIV/AIDS, a broad multidisciplinary approach is required
(Bernard et al., 2016). Zhou et al. (2014) posited a patient-centered, one-stop model of
care across diverse HIV care setting resulted in higher rates of HIV suppression for
individuals taking ART for six months.
Positive Healthcare Setting and Rapport with Personnel
The availability of and access to comprehensive, quality health care is a vital
determinant of optimal engagement in HIV care or medical services and ART adherence
(Micheni et al., 2017). Access to comprehensive quality care includes access to easily
accessible health care facilities that are resource-rich and has nonjudgmental personnel
who possess attitudes that foster positive relationships among their patients (Micheni et
al., 2017; Berger et al., 2015). Health care facilities that offer exceptional providerpatient communications, emphasized trust, respect, and HIV management knowledge
facilitated increased rates of optimal engagement in care among African American MSM
(Carey et al., 2018). Clinical providers who demonstrated compassion and respect
towards African American MSM, as well as health care facilities that offered an array of
services at one location and met the patients’ needs contributed to greater engagement in
care (Carey et al., 2018). Ogunbajo (2018) found establishing a rapport and familiarity
with health care staff positively influenced engagement in care.
Viral Suppression
The advancement of research relative to the management of HIV turned what
once was a deadly disease into a manageable chronic illness (WHO, 2017). Biomedical
interventions such as ART medications generated this shift in the morbidity and mortality
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of individuals infected with HIV (Lacey, Hanna, Miller, Foster & Russell, 2014). Daily
use of ART reduces the amount of HIV in the blood within six months or less to amounts
that are undetectable such that the health of the individuals living with HIV life is
preserved, while also preventing transmission of the virus to someone who is not infected
(National Institute of Allergy and Infectious Disease [NIAID], 2016). It is imperative that
HIV+ individuals adhere to their ART regimen to ensure the virus is durably undetected,
which suggest the virus is undetectable for six months after their initial undetectable test
result (NIAID, 2016). Young HIV+ individuals are less likely among all age groups to
be linked to care timely and to experience viral suppression (CDC, 2018c). Diverse
behavioral factors contribute to suboptimal ART adherence between young HIV+ MSM
and their timely engagement in the HIV continuum of care (Zanoni et al, 2014). Within
the U.S., a large percentage of individuals who are HIV+ are lost to follow-up and care
during each phase of the continuum (Kay et al., 2016). Young adults are susceptible to
adherence problems secondary to their psychosocial and cognitive developmental stage
(NIH, 2018c). Young MSM, especially AA MSM are particularly vulnerable to specific
ART adherence challenges that contribute to them experiencing the lowest rates of viral
suppression (Castel et al., 2016; Singh et al., 2014; Singh, Mitsch & Wu, 2017).
To mitigate this failure and to increase successful engagement in each phase of
the HIV care continuum, strategies that target MSM at the individual-level must be
developed (Kay et al., 2016). Medication adherence is a multidimensional phenomenon
in chronic illnesses such as HIV/AIDS, especially in young adults (Adefolalu, 2018).
Obtaining knowledge about behavioral factors that compromise health in young HIV+
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MSM garners a greater understanding of health-enhancing behaviors, which may result in
improved health outcomes (Adefolalu, 2018; Glanz et al., 2015). Behavioral skills
obtained from supportive relationships or support groups may assist with the employment
of effective relaxation skills that assist with issues relative to HIV disclosure or
empowering MSM to discuss openly the barriers to ART adherence, which may
subsequently result in improved treatment adherence and positive clinical outcomes
(Adefolalu, 2018; Glanz et al., 2015).
Variable Definitions
Terms commonly used throughout the study were:
Acquired immune deficiency syndrome (AIDS): A collection of diverse infections
or cancers that manifest in the body of an HIV+ individual whose has an extremely weak
immune system suggesting the persons illness has progress to a more severe syndrome,
which long-term may result in death (NIH, 2019).
Adherence: A process by which a proper treatment regimen is prescribed by a
clinical provider after engaging in an appropriate conversation with the patient
(Chakrabarti, 2014).
Age: Chronological number of years of being alive at the time of the interview
(GDPH, 2015).
Antiretroviral therapy (ART): A term that refers to medications that are used to
treat HIV infection, generally in a combination of three or more drugs (NIH, 2019).
ART Adherence: ART medication adherence refers to following a specific dose,
set of pills, spoonful, or injections of ART medications according to a prescribed
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schedule or special instructions. Adherence is measured by the participants use of health
care services, which represents individuals who had at least three clusters of
differentiation 4 (CD4) or HIV viral load testing documented in their medical record
(Wortley & Drenzek, 2015).
CD4 Count: A test that measure the infection fighting cells within an individual’s
body (NIH, 2019). These cells are commonly referred to as helper cells because they are
part of the white blood cells that help prevent infection (NIH, 2019). The CD4 count is
indicative of the presence of HIV and the associated damage to the body, it is a reflection
of a person’s immunity status (NIH, 2019).
Educational Attainment: The highest level of education an individual has
completed, defined as completing less than high school, receiving a high school diploma
or GED and more than high school (NCES, 2018).
Engagement in Care: A term that refers to a traditional source for primary HIV
health care (GDPH, 2015). HIV care is measured by participants use of health care
services, which represents individuals who had at least three clusters of differentiation 4
(CD4) or HIV viral load test documented in their medical record (GDPH, 2015).
Ethnicity: A term that is synonymous with race and is subdivided as American
Indian or Alaska Native, Asian, African American/African American, Hispanic or Latino,
White and Multiple races (GDPH, 2015).
Health Insurance or other ART coverage: Health insurance and other ART
coverage are terms used to categorize resources used to provide coverage for ART
medications 12 months prior to being interviewed for the Medical Mentoring Project
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(MMP). The ART coverage resources were categorized as private, public, unknown and
other health insurance (GDPH, 2015).
Income: Combined yearly pay in U.S. dollars. Yearly incomes will be recoded
from nine categories to three and will be represented as low, middle, and upper income
levels. Low income will be reflected as (1) (less than 10,000 to 49,999), (2) middle
income (50,999 to 299,999), and (3) upper income (300,000 to 499, 999). The recoded
income value ranges are based on the Federal Poverty Guidelines, which identifies a
household of four with incomes less than $25,100 per year as being low income (Office
of the Assistant Secretary for Planning and Evaluation, 2018).
Men who have sex with men (MSM): Men who identified themselves as being
homosexual, bisexual, or gay and who engage in a sexual encounter with one or more
men 12 months prior to the MMP interview (GDPH, 2015).
Viral Load Suppression: Replication of the HIV virus within an individual’s body
is commonly referred to as viral load. Decrease replication results in reductions in the
viral load or suppresses it to undetectable levels of HIV in the blood, which suggest the
levels are not detectable via testing (NIH, 2019). ART plays a critical role in reducing
HIV replication, suppression of the virus and HIV transmission (NIH, 2019).
Young adult: The universal definition for a young adult varied based on the
resource utilized. The age range was from 18 to 24 years of age, 20 to 25 years of age
and 18 to 39 years of age (Centers for Media and Child Health, 2018; Henderson &
Egbert, 2015; McDonagh, 2018). For the purposes of this research study, young adults
will consist of individuals 18 to 39 years of age.
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Assumptions
The following assumptions where made after reviewing the MMP surveillance
summary, as the information was not available for review. I assumed the data collection
process was conducted in an ethical manner such that participants did not feel pressured
or intimidated and that their right to privacy was not violated. Additionally, I assumed all
participants volunteered to be included in the research study and that informed consent
was obtained. Lastly, I assumed all participants were literate and responded with great
integrity to the research questions.
Scope and Delimitations
In this study, I will identify factors that influence adherence to ART therapy
among young MSM ages 18 to 39 who are HIV positive. The study will include data
from the MMP Surveillance Summary for persons receiving HIV care in the State of
Georgia from 2009 to 2013. The study is a cross-sectional, nationally recognized,
complex sample survey designed to evaluate clinical and behavior qualities of HIVinfected adults receiving outpatient medical care in the United States and Puerto Rico.
While there are many potential barriers to ART adherence among the target population,
the focus of this study will be on the social determinants (age, ethnicity, income,
educational attainment, ART insurance coverage), engagement in care and viral load
suppression and their relative influences on ART adherence. While these influences
among young adult MSM is the primary focus of the study, the findings may be relevant
and applicable to other MSM populations across the United States and globally. The SCT
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is the proposed theoretical framework that will support and direct the study because it has
been used as an invaluable public health tool in health promotion, especially among
youth and provides an essential foundation for understanding the development of human
behavior (Glanz et al., 2015).
Significance
HIV is a major contributor to morbidity and mortality among young MSM (CDC,
2018a). MSM are the only group in all transmission classifications whose incidence of
HIV infection increased (CDC, 2017). These young men are at an increased risk of HIV
infection because often they engage in unprotected anal sex and do not use medications
such as pre-exposure prophylaxis (PrEP) to protect themselves from HIV (NIH, 2018b).
According to Lall et al. (2015), there is a pressing need for research to be conducted on
factors influencing adherence to ART and retention in care among HIV+ adolescents and
young adults from key populations such as MSM. The study findings could provide
comprehensive knowledge about the relationship between factors that contribute to or
adversely affect an HIV+ young adult’s adherence to the ART treatment regimen such
that effective strategies may be developed that decrease nonadherence. Gaining
knowledge about factors that affect adherence could potentially lead to positive social
change by promoting sustainable reductions in young HIV+ MSM nonadherence to ART
as well as all HIV + youth under the age of 18. Further, implementing appropriate
interventions shaped by the findings from this study may result in reduced HIV
transmission rates and mortality among young HIV+ MSM. The results may ensure that
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young HIV+ MSM of color with the highest incidence and mortality rates have increased
awareness of the life-saving resources available to them.
These factors may include issues related to youth’s lack of knowledge about the
implications of them being HIV+ and their behavioral capability to adhere to ART as
well as how determinants of health such as age, ethnicity, educational attainment,
income, and ART insurance coverage influence ART adherence. These implications for
social change are significant because nonadherence to ART compromises the efficacy of
the existing medication regimen, limits optimization of future drug regimens in youth
who develop multidrug-resistant HIV, increases the potential threat of transmitting the
virus and death of youth (NIH, 2018).
Summary and Conclusion
Young adult African American MSM experience a disproportionate rate of newly
diagnosed HIV with rates three to five times higher than other ethnic groups (CDC,
2018c; Voisin et al., 2017). They were also at the highest risk for ART nonadherence
(CDC, 2017; Voisin et al., 2017). This is significant because ART is the gateway to
epidemiological control for HIV infection; however, young adult HIV+ African
American MSM are susceptible to poor adherence and viral suppression (Gross et al.,
2017; Hornschuh et al., 2017; Voisin et al., 2017). Additionally, they have lower rates of
retention throughout the HIV care continuum secondary to complex factors (Iacob et al.,
2017; Zanoni et al., 2014).
Nonadherence among the target population is multifactorial; therefore, strategies
to mitigate the increasing rates and improve treatment is necessary (Voisin et al., 2017).
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ART is the most significant factor in obtaining optimal viral load suppression and a vital
part of HIV prevention and treatment (Iacob et al., 2017; Voisin et al, 2017). Imminent
efforts to initiate and sustain the target population in HIV care may be contingent upon
close collaboration between the community-based organizations, HIV care facilities and
staff, state and federal governments, and young African American MSM themselves.
Working collaboratively among these groups may facilitate a more culturally and socially
acceptable environment and comprehensive HIV health care system (Liu et al., 2016).
Multilevel strategies that consist of individual, contextual and structural factors will be
essential to achieving optimal engagement in the HIV continuum (Micheni et al, 2017).
Consideration of these factors is highly encouraged when developing strategies, clinical
practice, and policy research that aims to understand how these factors influence an
individual’ health behaviors (Khahana, 2016). Additionally, future research is needed to
obtain a more comprehensive understanding of the collaborative relationship between
mental health, substance usage, and how cognitive processes affect ART adherence
(Gross et al., 2016).
Understanding the dynamics that result in suboptimal ART adherence is vital to
the morbidity and mortality of this population and may lead to positive social change, as
the findings could provide invaluable information about the relationship between factors
that promote adherence or those that adversely affect ART adherence (Berger et al.,
2015; Lall et al., 2015; NIH, 2018). In this regard, the intent of this study is to identify
factors that influence adherence to ART therapy among young adult African American
MSM who are HIV positive in the State of Georgia. A quantitative research study will be
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conducted to investigate the relationship between the social determinants (age, ethnicity,
income, and educational attainment), ART insurance coverage, engagement in care, viral
load suppression and ART adherence amongst the study population based on the
principles inherent in the SCT. The SCT was the theoretical concept selected because of
its focus on the dynamic and the mutual interface between personal factors, behavior and
the environment, which significantly influences ART adherence in young adults (Glanz et
al., 2015). Section 2 will provide an overview of the methodology that was used to
conduct this study.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this quantitative cross-sectional study was to identify factors that
influence adherence to ART therapy among young MSM who are HIV+ in the state of
Georgia. Considering that MSM are a key population with the highest rates of newly
diagnosed HIV within the United States (CDC, 2018), the proposed research has the
potential to fill a gap in the literature. The research will contribute to the literature
because there is limited evidence of an association between factors that could influence
young HIV+ MSM adherence to ART.
Section 2 will provide descriptions of the following information: Research design
and rationale, methodology, population, sampling and sampling procedures. It will also
provide a description of instrumentation and operationalization of constructs, and the data
analysis plan. Lastly, section 2 will describe the potential threats to validity (internal,
external, statistical, and construct), ethical processes, and a summary.
Research Design and Rationale
The quantitative research design was used to conduct this scientific investigation
to if there was a relationship between the independent variables ART insurance coverage,
engagement in care, and viral load suppression and the dependent variable ART
adherence. The covariates that were investigated were age, ethnicity, income, and
educational attainment. There were no mediating or moderating variables being
investigated. Inferential statistical analysis is one of the primary analytical technics used
in quantitative research and was appropriate for the study because this type of analysis
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offers information about the variances and relationships between two or more samples of
a population. Additionally, inferential statistical analysis permits hypothesis testing to
occur and the results may be globally applied to the entire population. Statistical
hypothesis testing is a process used to determine the probability that a specific hypothesis
is true (Frankfort-Nachmias & Leon-Guerrero, 2015).
The cross-sectional study design was the specific type of quantitative analysis
selected to conduct the study. The cross-sectional design addresses a fixed moment in
time; therefore, it can only measure variances between diverse people, subjects, or
phenomena instead of change (Salazar, Crosby, & DiClemente, 2015). Salazar et al.
(2015) said cross-sectional studies allow researchers to make inferences based on current
differences between populations such as HIV+ MSM. These differences may include
factors such as an individual’s socioeconomics, race/ethnicity, gender, and age.
Upon reviewing other quantitative research designs, it was determined that
descriptive statistical analysis would not provide the comparative exploration required to
answer research questions. Descriptive analysis involves summarizing and describing
data features in a study such that patterns may be identified in a manner that makes the
data easier to understand (Center for Innovation in Research and Teaching, [CIRT], n.d.).
The descriptive methodology does not provide information relevant to the research
question, as it does not provide a finding that supports the association between the
various measures or inferences that extend beyond the data. Other research designs
include experimental and quasi-experimental designs. Neither of the designs was an
acceptable research approach for this study because the study is not experimental in
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nature, as secondary data that is non-manipulative was used and participants were not
randomly assigned to treatment groups to ascertain the impact of ART on young adult
HIV+ MSM health outcomes. The cross-sectional design is the most appropriate
research approach required to advance knowledge in the discipline, as it measures the
association between the variables of interest.
Methodology
Population
The population of interest for the study is comprised of young adult HIV+ MSM
between the ages of 18 and 39 receiving HIV care in the State of Georgia from 2009 to
2013. According to the Georgia Department of Public Health (2015), there were
approximately 51,510 individuals in 2013 living within the state of Georgia diagnosed
with HIV, and 2,661 were newly diagnosed with HIV. The target population consisted of
314 individuals who identified themselves as homosexual or gay and 227 individuals who
fell within in the defined age range of 18 to 39 years.
Georgia Medical Monitoring Project (GMMP) and Medical Monitoring Project
The current dissertation study data are based on a secondary data analysis of the
(MMP a surveillance system that collects local and national data to obtain knowledge
about the experiences and needs of individuals living with HIV. The MMP data
collection is performed through a collaboration between state and local health
departments and the CDC (CDC, 2018). Data used to determine the affect social
determinants has on ART adherence in the target population was obtained from the
GMMP were used to conduct this study. All sampling was performed by the MMP and
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data were collected by the state of Georgia. According to the CDC (2018), all 50 U.S.
states, the District of Columbia, and Puerto Rico are eligible for participation in the
MMP; however, only 16 states and one U.S. territory were selected. The number of statebased AIDS cases determined whether a site was selected for participation in the GMMP
(CDC, 2018). The project period occurred 12 months prior to the interview unless
otherwise noted.
Sampling and Sampling Procedure
The GMMP surveillance summary reported unweighted sample sizes and
weighted incidence approximations with 95% confidence intervals for all behavioral and
clinical characteristics within the project period (GDPH, 2015). Variables with less than
five responses or a coefficient of variation of greater than or equal to 30 were not
reported for weighted prevalence estimates or 95% confidence intervals. Weighting is
significant because weighting allows adjustments to be made to account for unequal
probabilities of selection during sampling and improves the precision of survey estimates
(Pike, 2008). More specifically, weighting permits researchers to calculate estimations
and make inferences about specific populations via a sample (Banerjee & Chaudhury,
2010). This sampling strategy was chosen because according to the CDC (2018), of all
HIV+ individuals in medical care, 88% visited their HIV medical clinician at least once
during the first 4 months of a calendar year. Sampling was conducted during two
consecutive phases with the first stage of sampling being the state stage This stage of
sampling occurs at outpatient health care facilities that provided HIV care The second
personal stage consisted of HIV+ adults 18 years of age or older who engaged in one
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medical visit to a participating facility from January 1 to April 30 of each project year
(2009-2013). During the personal stage, 400 HIV+ individuals were selected from the
National HIV Surveillance System. Upon being selected, individuals were asked to
partake in interviews and answer questions about their HIV medical care and behaviors.
Additionally, upon agreeing to participate in the study, the MMP staff obtained
permission to review their medical records from outpatient healthcare facilities. Strict
protocols were employed to ensure the confidentiality the patients and the participating
healthcare facility. Participant and facility names were not shared with CDC or include in
any reports.
According to the CDC (2018d), from 2005 to 2014, the MMP only included
individuals receiving HIV medical care from HIV outpatient facilities; however, in 2015,
the program began recruiting all adults diagnosed with HIV, including those who are not
in HIV medical care.. Changing the sampling strategy allowed the research findings to
guide policy and financial decisions as a means of increasing engagement in care and
enhancing the quality of care HIV+ individuals residing in the U. S. received (CDC,
2018d).
Recruitment Procedures for Georgia Medical Monitoring Project (GMMP)
MMP personnel or the HIV medical facility personnel enrolled participants in the
study using strategies that were contingent upon the health care facilities, project area
needs, the local Institutional Review Board (IRB) requirements, and the number of
participants (GDPH, 2015). For participants enrolled by MMP personnel, the HIV
medical facility provided MMP personnel with the telephone numbers for everyone). For
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those enrolled by the HIV medical facility clinicians, select participants were contacted
via telephone, mail or in person communications and then by MMP personnel (Eligibility
requirements included participants being diagnosed as HIV+, 18 years of age or older at
the commencement of the PDP, no former participation in the MMP throughout the
existing facts gathering cycle, and must have received health care at the sampled facility
during the PDP (GDPH, 2015). Computer assisted individual interviews were used to
capture participant responses. During the initial data collection for the original study all
participants received approximately $50 in cash or the equivalent for their participation
after the interview, MMP personnel used an electronic application provided by CDC to
abstract participant-level data from their health care record (GDPH, 2015).
Obtaining GMMP Dataset for Dissertation Study
To gain access to the data set, I obtained approval of my research topic from the
Walden University (WU) IRB 06-24-19-0549210). Upon obtaining approval from
Walden University Research Office (WURO), I submitted a data request to the GDPH via
their public health information portal. GDPH IRB approval was determined once the
data request were received. No historical or legal documents were utilized as data
sources.
A power analysis was completed to ascertain the smallest sample size suitable to
detect the effect of a given test at the desired level of significance. More specifically, a
G*Power priori analysis was completed to ascertain the appropriate sample size. A priori
analysis is completed before a research study is conducted to ensure the projected sample
size is sufficient to attain adequate power thus reducing the risk of underpower (Beck,
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2013; Institute for Digital Research and Education, 2019). According to Aschengrau and
Seage (2014), power is the ability of a test to reject properly the null hypothesis when the
alternative hypothesis is true. To conduct this power analysis, secondary data will be
utilized. Based on GMMP Surveillance Summary, between 20 and 38 health care
facilities were sampled resulting in 400 participants from 2009 to 2013; however, in
reviewing the number of participants who actually completed the interview and whose
medical records were abstracted, there were 795 over the five-year review period .
Instrumentation and Operationalization of Constructs
The CDC developed the MMP research instrument in 2012 after the Adult/
Adolescent Spectrum of HIV Disease (ASD) and Supplement to HIV/AIDS
Surveillance (SHAS) projects were found to be limited in their usefulness. (The
instruments usefulness was inadequate because of their narrow geographical focus; the
inability to approximate fundamental indicators, such as the quality of care provided and
gaps in the availability of HIV health care services; and the inability to generalize the
finding to the broader HIV population secondary to inappropriate sampling, as
probability sampling was not conducted (CDC, 2012a). The MMP encompasses many of
the features of the previous instruments; however, it was intended to collect nationally
sampled population-based HIV surveillance data and to address the limitations inherent
in the ASD and SHAS instruments (CDC, 2012a).
All data used by the state of Georgia in the GMMP were obtained from the
national MMP data collection repository and disseminated intermittently to the state. Two
questionnaires, one short (20 minutes) and one long (45 minutes) were used to conduct
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the interviews. All interview questionnaires are available in English and Spanish and
consisted of 10 distinct modules designed to provide a synopsis of the present-day
epidemiology of HIV disease in the United States and Puerto Rico (CDC, 2012a; GDPH,
2015).
The Questionnaire Development System software applications used to conduct
interviews has a built-in automatic checker that assures high-quality data is collected
(CDC, 2012a). As an added level of assurance, the project coordinator or other
supervisory personnel observed 5% of all interviews to ensure data completeness and
quality. Additionally, episodic quality checks are conducted on the interviewers to ensure
the techniques used to administer the questionnaire are the same (CDC, 2012a). As it
relates to the medical record abstraction, the CDC provides training and has a call center
to assist with any questions. Furthermore, for quality control purposes, 5% of medical
records abstracted were re-abstracted by a second interviewer and then assessed for
discrepancies and completeness (CDC, 2012a).
As it relates to the GMMP data, the research questions were examined because
many of the questions asked using the survey instrument is related to and consistent with
the information contained in the GMMP data. More specifically, the survey instrument is
applicable to the research study and includes the selected variables such that hypotheses
testing may be conducted to assess the probability of various associations. The survey
questions were used among diverse HIV populations within the United States and were
inclusive of the target population of this study. Permission to utilize the instrument is not
required because it is located on CDC’s website and other public domains (GDPH, 2015).
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Table 1
Operationalization of Constructs
Variable
ART Adherence

Definition

A term that refers to
medications that are used to
treat HIV infection, generally
in a combination of three or
more drugs (NIH, 2019) and
the participants compliance
with the medical providers
prescription orders to include
the correct dose, schedule
and special instruction
(GDPH, 2015).

Measured by Survey
Question Responses
Question 1
Do any of your ART
medicines have special
instructions, such as “take
with food” or “on an empty
stomach” or “with plenty
of fluids”? If so, during the
past 3 days, how often did
you follow all of those
special instructions?
• Never
• Rare
• About half of the
time
• Most of the time
• Always
• Refused to answer
Don’t know (CDC,
2012b).
Question 2
Most antiretroviral
medicines need to be taken
on a schedule, such as “2
times a day” or “3 times a
day” or “every 8 hours.”
How closely did you
follow your specific
schedule
during the past 3 days?
• Never
• Rarely
(table continues)
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•
•
•
•
•

About half of the
time
Most of the time
Always
Refused to answer
Don’t know (CDC,
2012b).

Question 3
When was the last time you
missed any of your ART
medicines?
• Within the past
week
• 1-2 Weeks ago
• 3-4 Weeks ago
• 1-3 months ago
• More than 3 months
ago
• Never skip
medicines
• Refused to answer
• Don’t know (CDC,
2012b).
Age

Chronological age at the time Question 1
of the interview in years
(GDPH, 2015)
What is your date of birth?
(CDC, 2012b).

ART Insurance Coverage

Health insurance and other
ART coverage are terms
used to categorize resources
used to provide coverage for
ART medications 12 months
prior to being interviewed for
the Medical Mentoring
Project (MMP) (GDPH,
2015). The ART coverage
resources were categorized
as private, public, unknown

Question 1
During the past 12 months,
have you had any kind of
health insurance or health
coverage? This includes
Medicaid and Medicare.
(CDC, 2012b).
Question 2
(table continues)
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and other health insurance
(GDPH, 2015).

Educational Attainment

The highest level of
education an individual has
completed (may be defined
as completing less than high
school, receiving a high
school diploma or GED and
more than high school)
(National Center for
Educational Statistics, 2018).

During the past 12 months,
what were all the kinds of
health insurance or health
coverage you had?
• Private health
insurance
• Medicaid
• Medicare
• Ryan White
• Tricare or
CHAMPUS
• Veterans
Administration
coverage
• Other (Specify)
• Refused to answer
• Don’t know (CDC,
2012b).
Question 1
What is the highest level of
education you completed?
• Never attended
school
• Grades 1 through 8
• Grades 9 through
11
• Grade 12 or GED
• Some college,
associate’s degree,
or technical degree
• Bachelor’s degree
• Any post graduate
studies
• Refused to answer
• Don’t know (CDC,
2012b).
(table continues)
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Ethnicity

Income

A term that is synonymous
with race and is subdivided
as American Indian or
Alaska Native, Asian,
African American/African
American, Hispanic or
Latino, White and Multiple
races (GDPH, 2015).

Question 1

Combined yearly household
income in U.S. dollars
(GDPH, 2015)

Question 1

Which racial group or
groups do you consider
yourself to be in? You may
choose more than one
option.
• American Indian or
Alaska Native
• Asian
• African American
or African
American
• Native Hawaiian or
Other Pacific
Islander
• White
• Refused to answer
• Don’t know (CDC,
2012b).

In 2011(2012), what was
your combined monthly or
yearly household income
from all sources before
taxes? When I say
combined household
income, I mean the total
amount of money from all
people living in the
household (CDC 2012b).
Question 2
The interviewer then
stated: Please take a look at
Response Card A
(table continues)
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and tell me the letter that
corresponds to either your
monthly or yearly
household income before
taxes. (CDC, 2012b).
Monthly Income
a. $0 to $41
b. $417 to $833
c. $834 to $1249
d. $1250 to $1666
e. $1667 to $2499
f. $2500 to $3333.
g. $3334 to $4166
h. $4167 to $6249
i. $6250 or more
77 Refused to answer
88 Don’t know (CDC,
2012b).
Yearly Income
j. $0 to $4,999
k. $5,000 to $9,999
l. $10,000 to $14,999
m. $15,000 to $19,999
n. $20,000 to $29,999
o. $30,000 to $39,9993334
p. $40,000 to $49,999
q. $50,000 to $74,999
r. $75,000 or more
77 Refused to answer
88 Don’t know (CDC,
2012b)
Engagement in Care

A term that refers to a
traditional source for primary
HIV health care (GDPH,
2015). HIV care is measured
by participants use of health
care services, which
represents individuals who
had at least three clusters of

Question 1
During the past 12 months,
have you been to any other
doctor’s office or clinic for
your HIV medical care?
(CDC, 2012b).
(table continues)
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differentiation 4 (CD4) or
HIV viral load assessment
documented in their health
record (GDPH, 2015).
Viral Suppression

Replication of the HIV virus Question 1
within an individual’s body
is commonly referred to as
What was the result of your
the viral load. Decrease
most recent viral load test?
replication results in
reductions in the viral load or
• Below the level of
suppresses it to undetectable
detection,
levels of HIV in the blood,
undetectable
which suggest the levels are
• Detectable but less
not detectable via testing
than 5,000 viral
(NIH, 2019).
copies/ml
•

•

25,000 to 100,000
viral copies/ml
Greater than
100,000 viral
copies/ml
Refused to answer
Don’t know (CDC,
2012b)

Question 2
During the past 12 months,
how many viral load tests
have you had? (CDC,
2012b).
Information regarding the
variable/scale score was
not available in the data
summary
Source: Wortley & Drenzek, 2015
Data Analysis Plan
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Engagement in care and viral suppression are the independent variables, ART
adherence the dependent variable and the social determinates (age, educational
attainment, ethnicity, and income and ART insurance coverage) are the covariates.
Steiner (2015) said, covariates may influence the research outcomes; therefore, it is
important to include them in statistical analyses. Covariates assist with the explanation of
the research findings and increase the accuracy of the results and the power of the
statistical test (Steiner, 2015). Inferential statistical tests that might be used to test the
hypothesis includes correlations, regression and analysis of variance. The actual
statistical analysis conducted will be contingent upon how the variables are measured
(Frankfort-Nachmias & Leon Guerrero, 2015). The levels of measurement may be
nominal, ordinal, interval, or ratio (Marateb, Mansourian, & Farina, 2014).
SPSS software was used to conduct the statistical analysis and the outcomes
directed how the results were interpreted. Analytical results were interpreted as reject or
fail to reject the respective research hypothesis established at the beginning of the study.
A p-value or alpha of 0.05 were used as the level of significance. If the p-value is greater
than or equal to 0.05, we failed to reject the null hypothesis and if the p-value is less than
or equal to 0.05 we reject the null hypothesis. The confidence interval is the measure of
uncertainty around the primary result of statistical analysis (Fink, 2013). The confidence
intervals and significance level work collaboratively to describe research finding because
it is statistically better to use the P-value and confidence intervals instead of the P-value
and hypothesis testing (Fink, 2013; Dahiru, 2008).
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Data were prepared to ensure that there were no missing values and that all data
were valid (Devi & Kalia, 2015). Missing and inaccurate data may result in significant
problems related to the reliability and validity of the research conclusions (Devi & Kalia,
2015). Absent data may reduce statistical power, create bias in the estimate of
parameters, decrease the representativeness of the population samples and increase the
complexity of analysis, which threatens the validity of the research conclusions (Kang,
2013).
The following research questions were addressed:
RQ1: Is there a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia?
H01: There is no relationship between awareness about ART and adherence to
ART among young HIV+ MSM between the ages of 18 and 39 in Georgia.
H01: There is a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ2: Is there an association between age, ethnicity, educational attainment,
income, and ART insurance coverage and adherence to ART among young HIV+ MSM
between the ages of 18 and 39 in Georgia?
H02: There is no association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
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Ha2: There is an association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ3: Is there is a relationship between engagement in care, viral load
suppression, and adherence to ART among young HIV + MSM between the ages of 18
and 39 in Georgia?
H03: There is no relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Ha3: There is a relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Threats to Validity
Data preparation plays an important role in research, as does data reliability.
Reliability is the extent to which research can trust the source of the data (Burkholder,
Cox & Crawford, 2016). Reliable data is dependable, constant and trustworthy and can
produce consistent results (Burkholder et al., 2016). For research data to be valuable and
useful, it must be both reliable and valid. Validity in quantitative research is an
indication that research accurately measures what it was projected to measure and serves
as the central quality indicator (Burkholder et al., 2016; Creswell, 2013). There are
several distinct threats to validity that may negatively affect the research finding to
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include the internal, external, statistical conclusion, and construct validity (Creswell,
2013). Internal validity refers to the truth of inferences in research, as it relates to the
cause and effect relationship (Creswell, 2013). Threats to internal validity occur when
investigators use investigational steps, treatments or participant practices that threaten the
researcher’s capacity to extrapolate accurate data about the target population (Creswell,
2013). Threats to internal validity may include issues such as selection bias, statistical
regression, maturation, treatments and instrumentation (Creswell, 2013). This research
study will include the use of secondary data; rather than that obtained from experimental
research. In this regard, threats to internal validity should be less likely to occur or will
be minimal (Creswell, 2013).
External validity refers to the capacity of research finding to be generalized to and
across settings, individuals and times (Burkholder et al., 2016). Threats to external
validity may occur when research findings are generalized to groups not included in the
study or to the results of historical or prospective situations (Creswell, 2013). According
to Burkholder et al. (2016), utilizing the findings from secondary research such as that
used in this study decreases the threat to external validity as well as conducting a
comprehensive literature review.
Statistical conclusion validity refers to inferences made about the association
between two variables based on the accuracy of statistical testing results (Burkholder et
al., 2016). Threats to statistical conclusion validity occur when researchers inaccurately
draw conclusions secondary to low statistical power or violations of statistical
assumptions (Creswell, 2013). Data cleaning and outlier analysis are threats to this type
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of validity as well. The sampling process for the GMMP included a random selection of
participants, occurred at diverse HIV health care settings and all recruitment procedures
were clearly described; therefore, in this regard, there are no anticipated statistical
conclusion threats to validity. However, in lieu of the fact that diverse statistical testing
will be conducted to answer the proposed research questions, there is a potential threat to
statistical conclusion validity related to inadequate statistical power and violations of
statistical assumption (Creswell, 2013).
Construct validity is the degree in which research concepts are conceptualized and
operationalized in a study (Burkholder et al., 2016). Threats to construct validity occurs
when researchers do not properly define or measure variables (Creswell, 2013). While all
variables were defined, the variable measurements are unknown at this time and will not
be available until the actual data is obtained from the State of Georgia. Although the data
measurements are not available, I do not anticipate any threats to construct validity.
Additionally, secondary data analyses have the potential to increase the overall efficiency
of the research effort and support the basis for confidence in the validity of the analysis
(Cheng & Phillips, 2014).
Ethical Procedures
A formal request to WUIRB was completed to obtain the GMMP dataset. Only
secondary data obtained from the GDPH was utilized in the study; therefore, I did not
have any contact with human subjects. The GDPH required that an approved IRB form
be submitted with the formal request for data. I completed a request and obtained IRB
approval from the GDPH.
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The State of Georgia and CDC abstracted the data contained in the GMMP from
the MMP; therefore, the data remained anonymous, confidential, and impossible to
identify the participants. According to the CDC (2018d), strict protocols were established
to protect the confidentiality of participants. The patient names and healthcare facilities
were kept confidential and were not shared with CDC or included in any reporting (CDC,
2018d). Informed consent was obtained from all participants prior to them partaking in
the MMP. Additionally, MMP personnel (interviewers, data managers, and medical
record abstractors) were required to participate in a security and confidentiality training
consistent with that obtained by health department personnel who perform HIV/AIDS
surveillance (CDC, 2012a). All software developers participating in the surveillance data
collection for all HIV/AIDS projects must adhere to the Public Health Service Act’s
Assurance of Confidentiality (Sections 306 and 308(d)). This law asserted data obtained
via a surveillance system that may allow for the identification of an individual or that
established all information collected will be maintained with strict confidence, only used
for the reasons stated and would not be revealed or released without proper consent
(CDC, 2012a).
The CDC (2012a) determined that MMP was not experimental research; rather it
is a disease investigation initiative designed to use the data for disease control and policy
development. Since MMP is not considered to be research, it was not subjected to the
regulations applicable to human subjects inclusive of federal IRB evaluation and
endorsement. Although human subjects were not involved in the data collection, all
federal, state, and local MMP personnel were required to adhere to the ethical principles
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and standards, expected to respect and protect the privacy/confidentiality, and autonomy
of participants to the maximum level imaginable, thus ensuring there were no ethical
concerns related to the recruitment or data collection process (CDC, 2012a). According to
the GMMP (2015), there were no other ethical concerns indicated such as participant
deception, potential power imbalances or exploitation of participants (Creswell, 2013).
Summary
A quantitative cross-sectional study was proposed to identify factors that
influence adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia. The proposed dataset focuses on the behavior and clinical characteristics of
persons receiving HIV care in the state of Georgia from 2009 to 2013. Inferential
statistical analysis is the primary statistical technique that will be used to determine the
relationship between the variables and permits hypothesis testing to occur such that the
results may be generalized to the entire population. The research design and rationale for
its use were discussed as well as the methodology, target population, sampling and
sampling procedures, as described in the original MMP survey, instrumentation and
operationalization of SCT constructs, data analysis plan, threats to validity and ethical
concerns. Section 3 will detail the actual research results and findings obtained from the
data analysis.
Section 3: Presentation of the Results and Findings Section
Introduction
The purpose of this quantitative cross-sectional study was to investigate the
relationship between factors that influence ART adherence, which include social
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determinants (age, ethnicity, educational attainment, income, and ART insurance
coverage), engagement in care, and viral load suppression and ART adherence among
young adult MSM who are HIV+ between the ages of 18 and 39 in the state of Georgia.
The research questions and hypotheses were:
RQ1: Is there a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia?
H01: There is no relationship between awareness about ART and adherence to
ART among young HIV+ MSM between the ages of 18 and 39 in Georgia.
H01: There is a relationship between awareness about ART and adherence to ART
among young HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ2: Is there an association between age, ethnicity, educational attainment,
income, and ART insurance coverage and adherence to ART among young HIV+ MSM
between the ages of 18 and 39 in Georgia?
H02: There is no association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
Ha2: There is an association between age, gender, ethnicity, educational
attainment, income, and ART insurance coverage and adherence to ART among young
HIV+ MSM between the ages of 18 and 39 in Georgia.
RQ3: Is there is a relationship between engagement in care, viral load
suppression, and adherence to ART among young HIV + MSM between the ages of 18
and 39 in Georgia?
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H03: There is no relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Ha3: There is a relationship between engagement in care, viral load suppression,
and adherence to ART among young HIV+ MSM between the ages of 18 and 39 in
Georgia.
Section 3 details the data collection process for the secondary data, as well as
actual research results and findings obtained from the data analysis and a summary. The
initial analysis conducted involved descriptive statistics, which included a frequency
table inclusive of participant response percentages for each variable within in the study.
Descriptive statistical analysis was followed by chi square and logistical regression
analyses.
Data Collection of Secondary Data Set
The GDPH MMP secondary data was used to answer the research questions
guiding the current study. According to the GDPH (2015), the data collection time frame
for the original study was January 1 through April 30 during the project period 2009 to
2013. The aforementioned project period occurred 12 months prior to the interview
unless otherwise noted. MMP personnel or the HIV medical facility personnel recruited
and enrolled participants in the MMP study. A trained interviewer used a computer to
capture all responses during confidential individual interviews. Four hundred
participants were sampled annually from 28 to 38 of the sampled facilities. Over the 5year project period, 795 participants finished the questionnaire, their medical records
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were abstracted and used in the research study. The facilities sampled response rates
varied by year and ranged from 45% to 75% as did the participant response rates;
however, the participant response rates were much lower and ranged from 31% to 48%
during the project period.
An advantage of using a secondary data set is that the data were already collected
and available for use as evident in the GMMP data summary used during the planning
stages of this study. Despite the availability of the data, information related to awareness
was not presented in a manner conducive to the research study. There were four survey
items that covered topics related to prevention education and awareness, as outlined
below. The interview questions were as follows:
1. During the past 12 months, have you seen or received any
informational/educational materials such as posters, leaflets, pamphlets, or
videos that tell you how to protect you or your partners from HIV or other
STDs?
2. Have you talked to a counselor about HIV prevention?
3. Have you had a one-on-one conversation with a doctor, nurse, or other
healthcare worker about ways to protect yourself or your partners from getting
HIV or other sexually transmitted diseases? and
4. Have you participated in an organized session involving a small group of
people to discuss ways to protect yourself or your partners from getting HIV
or other sexually transmitted diseases?

68
The four variables were recorded by combining them into one awareness variable. This
was accomplished by assigning a value of Yes if the study participant’s responses to at
least one of the questions were Yes. To focus the relationship being studied to those who
were adherent or not, only the cases where a value of Yes, person is 100% adherent or
No, person is not 100% adherent” were used. Any cases with missing values or values of
NA, incomplete data, or not known were not selected. The original study variables with
the associated categories are displayed in Table 2 (Original Variables) and the recoded
variables are in Table 3 (Recoded Variables).
Table 2
Original Variables
Variable Name
Definitions
1. During the past 12
Prevention services received
months, have you seen or during 12 months before the
received any
interview
informational/educational
materials such as posters,
leaflets, pamphlets, or
videos that tell you how
to protect you or your
partners from HIV or
other STDs?

Variable Type
Categorical

2. Talked to counselor
about HIV prevention.

Prevention services received
during 12 months before the
interview

Categorical

3. Have you had a one-onone conversation with a
doctor, nurse, or other
health care worker about
ways to protect yourself
or your partners from
getting HIV or other?

Prevention services received
during 12 months before the
interview

Categorical
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4. Have you participated in
an organized session
involving a small group
of people to discuss ways
to protect yourself or
your partners from
getting HIV or other
sexually transmitted
diseases?

Prevention services received
during 12 months before the
interview

Categorical
(table continues)

Source: Wortley & Drenzek, 2015
Table 3
Recoded Prevention Values: Awareness of Importance of ART Adherence
1

Aware

2

Not Aware

Source: Wortley & Drenzek, 2015
There were 97 (52.7%) missing responses in the first question related to awareness. It is
important to manage missing data to reduce bias and draw valid assumptions about the
target population (Langkamp, Lehman, & Lemeshow, 2010). Additionally, it is
significant that researchers handle missing values first when recoding variables to prevent
recoding errors. This type of error occurs when researchers fail to tell SPSS explicitly
what to do with missing values (Kent University, 2017). If SPSS is not directed on how
to handle missing values, the system may recode missing values into one of the new valid
categories (Kent University, 2017).
While SPSS handles missing numeric data by omitting the missing values
automatically and excluding them from calculations, imputation is another method that
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may be used to address missing data (University of California Los Angeles Institute of
Digital Research and Education [UIDRE], 2016; Khang, 2013). Imputation is the process
of replacing missing data with an estimated value (Khang, 2013). To evaluate the
outcome of imputation on the recoded awareness variable, all missing data among the
four awareness variables, were replaced or imputed with No, the overall awareness
variable was recalculated, and the Chi Squares rerun.
According to the GDPH (2015), unweighted sample sizes and weighted incidence
approximations with 95% confidence intervals for all characteristics within the project
period were reported. Variables with less than five responses or a coefficient of variation
of greater than or equal to 30 were not reported for weighted prevalence estimates or 95%
confidence intervals (GDPH, 2015). Weighting is significant because it is a correction
technique utilized by researchers to compensate for the bias relative to effects of survey
non-respondents (Pike, 2008).
There was a discrepancy in the information received from the GDPH. The
secondary data set did not include one of the variables presented in Section 2.
Specifically, the data set did not include the variable that was proposed to serve as a
proxy for engagement in care. The variable was from Table 8 of the GDPH Medical
Monitoring Project surveillance summary (Clinical services provided during the 12
months before the interview, has a place for primary HIV care). In this regard, data
required to answer the third proposed research question is unavailable for analysis. In
addition to this discrepancy, the data set included four variables that supported prevention
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services (proxy for awareness) instead of three that were presented in the MMP data
summary and questionnaire.
From 2009 to 2013, 2,000 adults aged 18 or older who received HIV medical care
in an outpatient facility within the State of Georgia were surveyed for participation in the
MMP. Table 4 provides an overview of the description of that sample, which includes the
descriptive statics and demographic features. The final analytic sample consisted of 184
males who identified themselves as homosexual or gay.
Descriptive Analysis
Of the 184 study participants, 132 (71.7 %) were Black or African American, 26
(14.1%) White, and 26 (14.1 %) other. With respect to age, 119 (64.7%) were age 30 to
39 and 42 (22.8%) were age 25-29. The majority 88 (47.8%) of the population had some
college, an associates or technical degree and 44 (23.9%) completed grade 12 or a
Graduate Educational Development certificate (GED). A little over half 97 (52.7 %) had
annual incomes less than $19,999 and 49 (22.6%) had incomes that ranged from $20,000
to $39,999. Approximately 100 (54.3%) had health insurance that covered ART
medications. One hundred thirty-nine or 73.9% of the population were 100% adherent to
their ART medication dose, 90 (48.9%) were 100% adherent to their ART medication
instructions and 126 (68.5%) were 100% adherent to the ART medication schedule.
Sixty-eight or 37% of population were aware of the importance of ART adherence and 97
(52.7%) were missing data, which served as a limitation.
The descriptive analysis revealed that the data sample is not representative of the
population of interest, as 71.7% of the participants were African American. The target
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population was young HIV + MSM age 18-39 in Georgia. Since the data used is
secondary, the method for selection cannot be altered to account for the increased number
of African Americans in the sample size. Additionally, as previously stated the data
distribution among race/ethnic groups were changed by the GDPH to safeguard the
participant’s right to privacy. Samples without representativeness of the target population
do not allow statistical inferences to be made because they are not a reliable source in
which conclusions may be drawn about the reference population; therefore, a limitation
of the study. The GMMP study included geographically stratified random sampling
methods in which selection probabilities were utilized, sampling frame and lastly
participants were selected based on equal probability sampling methods (CDC, 2012).
Stratified random sampling permits researchers to obtain a sample population that is
representative of the total population being studied, improves accuracy and in general is a
more truthful depiction of the population than simple random sampling (University of
Central Arkansas, 2013; Salkind, 2012).
Table 4
Frequencies of Study Variables
Demographic

n = 184

%

184

100.0

White, non-Hispanic

26

14.1

Black, non-Hispanic

132

71.7

Combined gender and sex at
birth
Male
Race/Ethnicity

73
Other

26

Age groups at interview date

14.1
(table continues)

18-24

23

12.5

25-29

24

22.8

30-34

51

27.7

35-39

68

37.0

Grade 1 through 11

15

9.2

Grade 12 or GED

44

23.9

Some college, associate's

88

47.8

37

20.1

Highest level of education

degree, or technical degree
Bachelor's degree or
higher
Yearly income
$0 to $19,999

97

$20,000 to $39,999

49

>=$40,000

32

Don't know

6

Had any health insurance or
ART medicines (ARVs) were
paid by any health insurance
in the P12M
Yes, did have this type of ins.

100

Uninsured

13

Uninsured (RW/ADAP
only)

71

Source: Wortley & Drenzek, 2015
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Table 5
Frequencies of Awareness
Variable
Aware
Not Aware
Missing System

n = 184
68
19
97

%
37.0
10.3
52.7

Source: Wortley & Drenzek, 2015
Table 6
Frequencies of Adherences When Taking ART Medicine
Variable
Dose Adherence
Yes, person is 100%
adherent
No, person is not 100%
adherent
NA--Not taking ART
Incomplete Data Available
Schedule Adherence
Yes, person is 100%
adherent
No, person is not 100%
adherent
NA--Not taking ART
NA--No special instruction
needed
Instruction Adherence
Yes, person is 100%
adherent
No, person is not 100%
adherent
NA--Not taking ART
Yes, person is 100%
adherent
Source: Wortley & Drenzek, 2015

n = 184

%

136

73.9

25

13.6

21
2

11.4
1.1

90

48.9

40

21.7

21
31

11.4
16.8

126

68.5

37

20.1

21
126

11.4
68.5
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Study Results
To investigate the relationship between ART awareness and ART adherence by
dose, instruction and schedule, a series of chi-square analysis were conducted. Chisquare was the statistical tool selected to conduct this analysis because it determines
whether there is an association between categorical variables such as ART awareness and
adherence; however, does not make inferences about causation (McHugh, 2013). As a
nonparametric statistical test, data used to conduct the chi-square is not required to be
drawn for a normal distribution and the data are assumed to be random (FrankfortNachmias & Leon-Guerrero, 2015). Further, conclusions drawn for chi-square are
considered to be reliable if there is independence of observation and all expected
frequencies are greater than five (McHugh, 2013). If the cell frequencies are less than
five, SPSS will automatically display this as an error at the bottom of the chi-square test
table. SPSS automatically tested for these assumptions; therefore, no additional testing
was required (Kent State University. 2019).
To predict the association between age, gender, ethnicity, educational attainment,
income and ART insurance coverage and ART adherence, a series of binomial logistical
regressions were conducted. Binomial logistic regression was chosen as the statistical
tool to conduct this analysis because it is a predictive analysis, measures associations and
controls for effect of confounding variables (Stolzfus, 2011). Additionally, logistic
regression is an efficient and powerful method that researchers may use to analyze the
effect of a group of independent variables on a binary outcome such as ART adherence
by quantifying each of the social determinant’s unique contributions (Stolzful, 2011).
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Logistic regression requires a categorical variable as the dependent variable, allows
categorical variables as independent variables, and requires there is independence of
observation (Stolzful, 2011). All other assumptions are not applicable to the variables
contained within this data set, as they are not continuous variables (Stolzful, 2011).
Chi-Square Analysis
As it relates to the chi square analysis of awareness and ART medication dose
adherence, the p-value of .572 is greater than the alpha of .05; therefore, I failed to reject
the null hypothesis that awareness about HIV and the significance of taking ART
medications is not associated with medication dose adherence (McHuge, 2013). The final
analytical sample consisted of 80 observations. The chi-square analysis with 95%
confidence revealed a Person’s Chi-Square value X²(1) = .319, df = 1, p = .572. There
was not a statistically significant difference between awareness and dose adherence,
which suggest there is not sufficient evidence to support there is an association. To
review the chi-square results for awareness and dose adherence from the SPSS output
(see Appendix A1).
The chi square analysis of ART medication instruction adherence, the p-value of
.024 is less than the alpha of .05; therefore, I rejected the null hypothesis that awareness
about HIV and the significance of taking ART medications are not associated with
medication instruction adherence. The final analytical sample consisted of 59
observations. The chi-square analysis with 95% confidence revealed a Person’s ChiSquare value X²(1) = 5.089, df = 1, p = .024. There was a statistically significant
difference between awareness and instruction adherence, which suggest there is sufficient
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evidence to support there is an association. To review the chi-square results for awareness
and instruction adherence from the SPSS output (see Appendix A2).
To assess the strength of the association between awareness and instruction
adherence, a gamma test was conducted. This specific test was used because both
variables are dichotomous and may be considered ordinal (Frankfort-Nachmias & Leon
Guerrero, 2015). A gamma value may range from 0.0 to + 1.0 and provides information
that is indicative of the strength and direction of the association between the variables
(Frankfort-Nachmias & Leon Guerrero, 2015). There was a strong, positive association
between awareness and medication instruction adherence, as the Gamma yielded a value
of .674 (p = .048).
In the instance of awareness and ART medication schedule adherence, the p-value
of .083 is greater than the alpha of .05; therefore, I failed to reject the null hypothesis that
awareness about HIV and the significance of taking ART medications is not associated
with medication scheduling adherence. The final analytic sample consisted of 80
observations. The chi-square analysis with 95% confidence revealed a Person’s ChiSquare value X²(1) = 3.013, df = 1, p = .083. There was not a statistically significant
difference between awareness and schedule adherence, which suggest there is not
sufficient evidence to support there is an association. To review the chi-square results for
awareness and schedule adherence from the SPSS output (see Appendix A3).
Regression Analysis
The final analytic sample consisted of 161 observations without missing
variables. Binomial Logistic Regression was used to investigate the association between

78
age, race, educational level, and the availability of health insurance for ART medications
to predict medication dose adherence. The logistic regression with 95% confidence
yielded that the social determinates (age, race/ethnicity, educational level and health
insurance coverage) were not statistically significant in predicting dose adherence. More
specifically, the level of significance was as follows: age (p =.208), race/ethnicity (p
=.760), educational level (p = .194) and health insurance coverage (p = .190). Since the
aforementioned p-values were greater than alpha .05, we fail to reject the null hypothesis
that age, race, educational level and the availability of health insurance for ART
medications is not associated with predicting medication dose adherence. In lieu of a lack
of statistical significance in predicting dose adherence, no additional testing was
conducted. The Binomial Logistic Regression Likelihood Ratio test results for age, race,
educational level and health insurance predicting medication dose adherence are
displayed in Table 7.
Table 7
Likelihood Ratio Tests
Model Fitting
Criteria
-2 Log
Likelihood of
Reduced
Effect
Model
Intercept
70.675
Age groups at interview
75.220
date

Likelihood Ratio Tests

Chi-Square
.000
4.545

df

Sig.
0
3

.
.208
(table continues)
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Race/Ethnicity
71.224
Highest level of
75.392
education
Had any health
73.994
insurance or ART
medicines (ARVs) were
paid by any health
insurance in the P12M
Source: Wortley & Drenzek, 2015

.549
4.718

2
3

.760
.194

3.319

2

.190

The final analytic sample consisted of 130 observations with no missing variables.
Binomial Logistic Regression was used to investigate the association between age, race,
educational level, and the availability of health insurance for ART medications to predict
medication instruction adherence. The logistic regression with 95% confidence yielded
that race/ethnicity (p = .039) and educational level (p = .28) were statistically significant
predictors of medication instruction adherence. The Cox and Snell Pseudo R-Square test
was calculated and yielded that the model explains 11.7% of the variance in the
dependent or response variable (Menard, 2010). Further analysis of the regression model
revealed that White Non-Hispanic persons (y =1, p< .029) had an (Odd ratio [OR] =
.168), which reflected a higher likelihood of adhering to instructions than persons of
other races/ethnicities, Black (y = 2, p = .473), other (y = 9, no value). In addition,
persons with educational levels from grades 1 through 11 (Highest level of education = 3,
p = .048, OR = .189) and persons with some college, associate degree, or technical
degree (Highest level of education = 5, p = .028) had an (OR = .245), which reflected a
higher likelihood of adhering to instructions than persons with other educational levels.
The odds ratio measures the relationship between an exposure and an outcome and may
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be used to determine if a specific treatment is considered a ‘risk factor’ for a specific
outcome (Szumilas, 2010). An OR equal to one suggest an exposure does not influence
the odds of an outcome. While an OR greater than one suggests an exposure is
associated with a higher odds of an outcome compared to an OR less than one, which
suggest an exposure is associated with a lower odds of an outcome. To review the
Binomial Logistic Regression results for age, race, educational level and health insurance
predicting medication instruction adherence (see Appendix B1) and for the Cox and Snell
Pseudo R-Square (see Appendix B2).
The final analytic sample consisted of 163 observations with no missing variables.
Binomial logistic regression was used to investigate the association between age, race,
educational attainment, and the availability of health insurance for ART medications to
predict medication schedule adherence. The logistic regression with 95% confidence
yielded that educational attainment was a statistically significant predictor of medication
schedule adherence (p = .002). The Cox and Snell Pseudo R-Square test yielded that the
model explained 16.8% of the variance in the dependent variable. Further analysis of the
regression model revealed that persons with educational attainment levels from grades 1
through 11 (highest level of education = 3, p = .000, OR =1.056) and persons in grade 12
and those with a GED (highest level of education = 4, p = .000, OR = 1.363), which
reflected a higher likelihood of adhering to the medication schedule. To review the
logistic regression results for age, race, educational level and health insurance predicting
medication schedule adherence (see Appendix B3) and for the Cox and Snell Pseudo RSquare test (see Appendix B4).
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Summary
In Section 3, I investigated the relationship between ART awareness and ART
adherence by dose, instruction and schedule among young HIV+ MSM age 18-39 in
Georgia. The association between age, gender, ethnicity, educational attainment, income
and ART insurance coverage and ART adherence were also investigated. Seven hundred
and ninety-five MSM participants finished the questionnaire and their medical records
were abstracted for use in the research study. Although 795 participants were recruited,
only 184 of those participants identified themselves and being MSM and age 18 to 39.
Data obtained from the GMMP were analyzed using chi-square and binomial logistic
regression. The results of each statistical analysis were utilized to answer two of the three
proposed research questions and the hypothesis. RQ3 was not investigated because the
dataset did not contain the appropriate variables.
Chi-square analysis was used to answer RQ1. The recoded ART awareness
variables were used to conduct the chi-square statistical analysis. The dependent variable,
ART adherence varied based on dose, instruction, and schedule medication adherence.
The chi-square analysis for awareness about ART based on dose medication adherence
revealed a Pearson chi-square value of χ2 (1) = .319, with p = .572. This suggested there
were no significant differences in terms of medication dose adherence based on
awareness. The chi-square analysis for awareness based on medication instruction
adherence revealed a Pearson chi-square value χ2 (1) = 5.089, p= .024. This suggested
there was a significant difference in medication instruction adherence based on
awareness. The Gamma test of association revealed a value of .674, suggesting there was
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a strong positive relationship between medication instruction adherence and awareness.
The chi-square analysis for awareness based on medication schedule adherence revealed
a Pearson chi-square value χ2 (1) = 3.013, p = .083. This suggested there was no
significant difference in medication dose adherence based on awareness. There was no
relationship between ART awareness based on ART medication dose and schedule
among young HIV+ MSM between the ages of 18 and 39 in Georgia. However, there was
a statistically significant relationship between ART awareness based on ART medication
instruction among young HIV+ MSM age 18-39 in Georgia.
Binomial logistic regression analysis was used to answer RQ2. The independent
variables were social determinants (age, ethnicity, educational attainment, income, and
ART insurance coverage). The dependent variable, ART adherence varied based on dose,
instruction, and schedule medication adherence. A regression analysis for predicting
medication dose adherence based on social determinants revealed that the variables were
not statistically significantly related. The regression analysis for predicting medication
instruction adherence based on the social determinants revealed that race/ethnicity
(p=.039) and educational attainment (p = .028) were statistically significant predictors of
medication instruction adherence. The Cox and Snell Pseudo R-Square revealed that the
model explained 11.7% of the variance in the dependent variable. The social determines
of age, insurance coverage were not statistically significant for predicting ART
medication instruction adherence. Additionally, the model revealed that Whites had a
higher likelihood of adhering to medications instructions than other races/ethnicities.
Individuals with education attainment levels consistent with grades 1 through 11 and
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those with some college, an associate’s or technical degree had a higher likelihood of
adhering to ART medication instructions than other educational attainment levels. The
regression analysis for predicting medication schedule adherence based on the social
determinants revealed that educational attainment (p = .002) was a statically significant
predictor of medication schedule adherence. The Cox and Snell Pseudo R-Square
revealed that the model explains 16.8 % of the variance in the dependent variable.
Individuals with education attainment levels consistent with grades 1 through 12 had a
higher likelihood of adhering to ART medication schedule.
A summation of the binomial logistic regression model revealed that there was
not a statistically significant relationship between the social determinants for ART
medication dose adherence. Additionally, there was not a statistically significant
relationship between age, income, and ART insurance coverage and adherence to ART
medications based on ART medication instruction adherence among young HIV+ MSM
age 18-39 in Georgia. However, there was a statistically significant relationship between
educational attainment and ART medication instruction and schedule adherence to ART
among young HIV+ MSM age 18-39 in Georgia. There was also a statistically significant
relationship between race/ethnicity and ART medication instruction adherence among
young HIV+ MSM age 18-39 in Georgia. White non-Hispanics had a higher likelihood of
adhering to medication instructions than other races/ethnicities. Persons with educational
levels from grades 1 through 11 and persons with some college, an associate’s degree or
technical degrees had higher likelihood of adhering to medication instructions than
persons with other educational levels.
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Section 4 will reintroduce the study by restating the purpose and nature of the
study. Additionally, it will provide the rationale for why the research was conducted.
Section 4 will also include information about the interpretation of the findings,
limitations of the study, implications for professional practice, and social change.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this quantitative cross-sectional study was to investigate the
relationship between factors that influence ART adherence, which include social
determinants (age, ethnicity, educational attainment, income, and ART insurance
coverage), engagement in care, and viral load suppression among young adult MSM with
HIV who are between the ages of 18 and 39 in the state of Georgia. Young adults,
especially AA MSM have the lowest rates of ART adherence among all age groups;
however, individuals between the ages of 13 and 24 experience greater than 50% of all
new HIV infections, and have HIV rates that are three to five times higher than other
ethnic groups (Voisin et al., 2017). Despite the availability of biomedical interventions
such as ART, young MSM continue to experience suboptimal rates of adherence and are
recognized as one of the most vulnerable populations for HIV infection (Bekker &
Hosek, 2015; Voisin et al., 2017). Exploration of the research topic could help to fill the
gap in research and practice among young adult HIV + MSM who experience
disproportionately high rates of new HIV infection compared to other MSM populations.
Delineating factors that contribute to the increased rates of newly diagnosed HIV
infections may assist in determining factors that contribute to youth’s nonadherence to
ART and provide insights regarding the significance of creating young adult-centered
prevention strategies within a social-economic context for key populations such as MSM.
Secondary data used to measure ART adherence obtained from the GDPH
GMMP was used to conduct the analysis. This original data set consisted of 400
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participants who were sampled annually from 28 to 38 of the sampled facilities (GDPH,
2015). Over the five-year project period of the original study, 795 participants finished
the questionnaire, and their medical records were abstracted and used in the research
study (GDPH, 2015). Of the 795 individuals who completed the questionnaire, only 227
were 18 to 39 years of age. The final analytical sample consisted of 184 males who
identified as homosexual or gay. The descriptive analysis of the sample included 132
participants (71.7%) who were Black or African American, 26 (14.1%) White, and 26
(14.1 %) other. With respect to age, 119 (64.7%) were between the ages of 30 and 39 and
42 (22.8%) were between 25 and29. A majority of 88 (47.8%) participants had some
college, associates, or technical degree and 44 (23.9%) completed grade 12 or a Graduate
Educational Development (GED) certificate. A little over half or 97 (52.7%) had annual
incomes less than $19,999 and 49 (22.6%) had incomes that ranged from $20,000 to
$39,999. One hundred (54.3%) had health insurance that covered ART medications. One
hundred thirty-nine or 73.9% of the population were 100% adherent to their ART
medication dose, while 90 (48.9%) were 100% adherent to their ART medication
instructions and 126 (68.5%) were 100% adherent to the ART medication schedule.
Sixty-eight or 37% of population were aware of the importance of ART adherence and 97
(52.7%) were missing data.
The statistical tests used to explore the research questions were chi-square and
binomial logistic regression. The chi-square analysis indicated there was not a
statistically significant relationship between ART awareness and ART medication dose
and schedule; however, there was a statistically significant relationship between ART
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awareness and ART medication instruction among young HIV+ MSM between the ages
of 18 and 39 in Georgia.
The binomial logistic regression indicated there was not a statistically significant
relationship between the social determinants for ART medication dose adherence.
Additionally, there was not a statistically significant relationship between age, income,
and ART insurance coverage and adherence to ART medications and ART medication
instruction adherence among young HIV+ MSM between the ages of 18 and 39 in
Georgia. There was a statistically significant relationship between educational attainment
and ART medication instruction and schedule adherence to ART among young HIV+
MSM between the ages of 18 and 39 in Georgia. There was also a statistically significant
relationship between race/ethnicity and ART medication instruction adherence among
young HIV+ MSM between the ages of 18 and 39 in Georgia. White non-Hispanics had a
higher likelihood of adhering to medication instructions than other races/ethnicities.
Persons with educational levels from grades 1 through 11 and persons with some college,
associate’s, or technical degrees had a higher likelihood of adhering to medication
instructions than those with other educational levels (grade 12 or GED and bachelor’s
degree).
Section 4 will detail the interpretation of the findings and limitations of the study.
It will also provide recommendations for further research and implications for
professional practice. Lastly, section 4 will detail the final conclusions for the study.
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Interpretation of Findings
ART medication adherence is important in controlling viral replication,
maintaining health, and reducing viral transmission, and is a significant element in the
HIV treatment regimen because it reduces the amount of HIV in an individual’s blood.
The purpose of this study was to investigate the relationship between factors that
influence ART adherence such as diverse social determinants, engagement in care, viral
load suppression, and ART adherence among young adult MSM who are HIV+ between
the ages of 18 and 39.
The study showed that all social determinants (age, race/ethnicity, educational
attainment, income, and ART insurance coverage) were associated with and have the
potential to influence ART adherence and served as barriers to optimal ART adherence.
Barriers such as lack of engagement and retention of care and socio-demographics. My
research did not support the assertion that all social determinants influence ART
adherence. Specifically, the study showed that age, income, and ART insurance coverage
did not have a statistically significant relationship with awareness and adherence to ART
dose, instruction, and schedule or between social determinants and ART adherence to
dose, instruction, and schedule.
The study showed that young HIV+ individuals are constantly at the highest risk
for suboptimal and nonadherence to care at each stage of the HIV continuum.
Additionally, young adults experience poorer rates of retention in care, greater delays in
the initiation of ART, and suboptimal rates of viral suppression compared to older adults
(Shaw & Amico, 2016). Kay et al. (2017) said the availability of health insurance
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influences all stages of the HIV continuum of care. Young adults with HIV/AIDS are
among those at higher risk for not having health insurance and experience overall lower
rates of health insurance coverage than any other age group (Coetzee et al., 2015;
Spencer et al., 2018). According to Nachega et al. (2015), suboptimal ART adherence is
related to unemployment and limited fiscal resources.
The statistically significant chi-square results involved awareness and ART
medication instruction among young HIV+ MSM between the ages of 18 and 39 in
Georgia. The regression model also revealed statistically significant relationships
between educational attainment and ART medication instruction and schedule adherence.
Additionally, there was a statistically significant relationship between race/ethnicity and
ART medication instruction adherence. The statistically significant research findings of
my study are consistent with the literature review findings. Specifically, the study showed
that there was a positive association between awareness and medication instruction
adherence. El-Rachidi et al. (2017) stated young adults may not adhere to their
medication regimen because of their lack of knowledge and awareness about HIV or
significance of treatment modalities. Educational attainment was a statistically significant
predictor of medication instruction adherence and individuals with higher levels of
education were more likely to adhere to ART medication instructions. HIV+ individuals
with lower educational attainment experience worse health outcomes after they initiate
ART because of their nonadherence (del Amo et al., 2017). Additionally, del Amo et al.
(2017) study showed that race/ethnicity was a statistically significant predictor of
medication instruction adherence. According to Kalichman (2016), racial/ethnic-based
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based medical mistrust, late diagnosis, and poor ART adherence are significant predictors
of ART nonadherence among people who are HIV+.
The study findings provided evidence to support the theoretical foundation of this
study and were consistent with prior research. The study was based on the principles
inherent to the SCT, which assumes there is a dynamic and reciprocal interaction of
personal factors such as ART awareness about HIV prevention and treatment, and the
significance ART adherence plays in living a longer, healthier life and how it reduces the
risk of HIV transmission. The significant relationship between awareness, race/ethnicity
and educational attainment to ART adherence demonstrates the interaction of the three
factors (personal, behavior, and environmental) of the SCT. The SCT is relevant to the
management and treatment of chronic diseases such as HIV and the finding of this study,
as it may assist individuals with becoming more aware or knowledgeable about their HIV
diagnosis and the importance of maintaining optimal adherence to ART.
Limitations of the Study
The research study had several limitations. The study was based on secondary
cross-sectional data that was not designed to answer the research questions or to test the
specific hypothesis of this study. Additionally, a cross-sectional study does not allow for
the prediction of causation (Gross, Hosek, Richards, & Hernandez, 2016). The data was
collected via self-reported survey data. Self- reported data may be embellished;
respondents may be too uncomfortable or ashamed to reveal private details; and many
biases may affect the results, such as social desirability bias. This type of bias occurs
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when participants give positive self-descriptions or over or under report behaviors
(Ananthram, 2016).
Additionally, the data set was manipulated by the GDPH so that sample sizes less
than five were combined with other categories to ensure there was not a breach in the
survey participant’s confidentiality. The GDPH sponsor shared this information with the
researcher. GDPH also included four research questions relative to prevention education
or awareness that was not reflected in the GMMP surveillance summary. This summary
was used exclusively to draft Sections 1 (Foundation of the Study and Literature Review)
and Section 2 (Research Design and Data Collection).
Other limitations of the study included missing variables. Fifty-two percent of the
participant responses were missing from the first question related to awareness. Missing
data has the potential to not only reduce the statistical power of a study, but may also
produce biased estimates, resulting in invalid conclusions (Khang, 2013). Additionally,
missing data may decrease the representativeness of the population sample and increase
the complexity of analysis, which threatens the validity of the research conclusions
(Kang, 2013). The data set did not include the variable that was proposed to serve as the
proxy for engagement in care. The variable was from Table 8 of the GDPH MMP data
summary (Clinical services provided during the 12 months before the interview, has a
place for primary HIV care). In this regard, data required to answer the third proposed
research question was unavailable for analysis. In addition to this discrepancy, the data
set included four variables that supported prevention services (proxy for awareness)
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instead of three that were presented in the MMP data summary and questionnaire. The
Cochran formula for smaller sample sizes was used to calculate the sample size.

Figure 2. Cochran Formula for Smaller Sample.
In the equation, N is the population size, n0 is the recommended sample sized based on a
95% confidence level (CI). A CI of 95 % yields a critical value (Z) of 1.96 and a margin
of error of 0.5, which is 385. The number of participants age 18-39 is 227; therefore, N=
227. n= n0 (385)/ 1+ (n0 (385) - 1)/ N (227) = 385/1+ (384/227) = 385/1+ 2.69 =
385/2.69 = 143. The projected sample size is lower than the actual sample size of 184.
The final analytic sample size was small (N = 184) and it was not reflective of the target
population, as 71.7% of participants were African American and the target population
was young HIV+ MSM age 18-39 in Georgia. Since the sample is not representative of
the target population, it does not serve as a reliable source to draw statistical inferences
about the referenced population. A larger sample size will yield greater credibility to the
study, as the results are more reliable with greater precision and power, which allows
researchers to draw meaningful conclusions (Faber & Fonseca, 2014). Notwithstanding
the sample size and power of the study sample, the finding may have limited
generalizability to the entire population because this is a cross sectional study thus

93
serving as a potential threat to the internal validity. The history and selection processes
may serve as threats to the internal validity of the study. Specifically, during the fouryear time period the study was conducted, participants may have experienced life events
that influenced the outcome of the finding. Additionally, all participants were selected
based on predetermined characteristics that may contribute to the study outcomes thus
threatening the internal validity of the research conclusions.
Recommendations for Future Research
A qualitative study may be employed to ascertain and obtain greater
understanding of the implications of how the social determinants influence ART
adherence. While the study revealed there was not a statistically significant relationship
between age, income and ART insurance coverage and adherence to ART medication
dose and instruction adherence, the literature revealed there was a relationship between
ART adherence and all the social determinants. A qualitative study could provide clarity
about the views and feelings of young HIV+ MSM and interpret their experiences in a
manner that offers explanations for their behavior within a given situation or
environment. A qualitative study may also assist in uncovering trends in the population’s
thoughts and opinions and delve deeper into the health-related problems associated with
young adult HIV+ MSM adherence to ART.
Future research may include using a more diverse population in the conduction of
a longitudinal research design, which would provide greater credibility for a prediction
model for ART adherence outcomes. A longitudinal study includes both quantitative and
qualitative data, and occurs over time; therefore, it may be time consuming and expensive
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to conduct (Caruana et al., 2015). Nevertheless, longitudinal studies are effective in
determining patterns over time, exploring the relationship between risk factors and the
development of disease, and outcomes of treatments over diverse lengths of time
(Caruana et al., 2015). Additionally, these studies have greater power than the current
cross-sectional study and can identify changes or difference in the characteristics of the
target population at the group and individual level. Further research is needed to explore
in greater detail the variables that were predictive of HIV+ MSM adherence to ART,
which included awareness, educational attainment, and race/ethnicity. Future research is
critical for developing interventions that may mitigate and abate obstacles to optimize
ART adherence among young adults, especially challenges relative to the influence social
determinants have on adherence.
Implications for Professional Practice and Social Change
Implications for professional practice relative to the study findings may assist
public health practitioners with understanding the significance of HIV prevention
strategies and awareness about the benefits of ART adherence. It may also encourage
practitioners to use clear and concise medication instructions about the significance of
ART adherence among all populations. More specifically, the findings may assist
practitioners with understanding the importance of implementing strategies relative to
adherence to the medication schedule and instructions targeting young HIV+ MSM of
color. Likewise, practitioners should be aware that race/ethnicity and educational
attainment played a role in how young HIV+ MSM adhere to their medication
instructions. According to Iacob et al. (2017), limited communication skills and
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educational attainment and other factors contributed to ART nonadherence. Additionally,
as a result of these findings, public health practice and policy may be influenced in a
manner that facilitates positive change.
The findings may also have implications for social change in that there are limited
studies that address ART adherence among the target population. Increased adherence to
ART is essential to reducing HIV transmission as well as the quality of life, mortality and
morbidity of MSM living with HIV (Lall et al., 2015; NIH, 2018). The knowledge gained
from this study, specifically knowledge relative to how awareness about the significance
of HIV prevention and ART adherence, educational attainment and race/ethnicity
influence ART medication adherence by instruction and schedule may assist in the
development of more effective strategies. Strategies that may increase the rate of ART
adherence, decrease the rates of HIV transmission among young HIV+ MSM and
ultimately prevent death.
Conclusion
Suboptimal adherence was found to be associated with awareness and ART
medication instruction adherence, educational attainment and ART medication
instruction and schedule adherence and race/ethnicity and ART medication instruction
adherence. The study revealed that the most significant statistical association related to
ART adherence was related to medication instruction adherence. The study showed that
awareness, educational attainment and race/ethnicity had a statistically significant
positive association with ART medication instruction adherence. These findings have
contributed to the existing knowledge by validating factors that influence ART adherence
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among young HIV+ MSM in the state of Georgia. The findings are also consistent with
numerous studies related to the influence social determinants have on optimal ART
adherence.
It is paramount that there is a comprehensive understanding of factors that
influence how MSM comprehend the significance of ART adherence through the HIV
continuum. Continuous and ongoing retention in HIV care is a significant indicator for
the achievement of optimal HIV management and a critical element of successful
treatment and prevention (Colasanti et al., 2016). A comprehensive understanding of the
dynamic factors that contribute to suboptimal ART adherence is vital to the morbidity
and mortality of the MSM population within the U.S. and globally (Maskew et al.,
2016).These finding may lead to positive social change, as they may provide valuable
knowledge about the association between factors that promote adherence or those that
adversely contribute to suboptimal ART adherence. Gaining knowledge about factors that
contribute to youth’s nonadherence to ART provides insights relative to the significance
of creating young adult-centered prevention strategies within a social-economic context
for key populations such as MSM.

97
References
Adefolalu, A. (2018). Cognitive-behavioural theories and adherence: Application and
relevance in antiretroviral therapy. South African Journal of HIV Medicine, 19(1),
762. doi:10.4102/sajhivmed.v19i1.762
Aho et al. (2014). Exploring risk behaviors and vulnerability for HIV among men who
have sex with men in Abidjan, Cote d′Ivoire: Poor knowledge, homophobia and
sexual violence. Plos One, 9(6), e99591. doi:10.1371/journal.pone.0099591
Ammona, N., Mason, S. & Corkery, B. (2018). Factors impacting antiretroviral therapy
adherence among human immunodeficiency virus-positive adolescents in SubSaharan Africa: A systematic review. Public Health, 157, 20-31. doi:
10.1016/j.puhe.2017.12.010
Ananthram, S. (2016). Social desirability bias. In Alan Nankervis, Chris Rowley,
Noorziah Salleh (ed.) Asia Pacific human resource management and
organizational effectiveness (pp. 87-109). doi:10.1016/B978-0-08-1006436.00005Artiga, S. & Hinton, E. (2018). Beyond health care: The role of social determinants in
promoting ealth and health equity. San Franciso, CA: Henry J. Kaiser Family
Foundation.
Aschengrau, A., & Seage, G. R., III. (2014). Essentials of epidemiology in public health
(3rd ed.). Burlington, MA: Jones & Bartlett.
Assistant Secretary for Planning and Evaluation. (2018). Poverty Guidelines. Retrieved
https://aspe.hhs.gov/2018-poverty-guidelines

98
Austin, Z. & Sutton, J. (2014). Qualitative research: Getting started. Canadian Journal
of Hospital Pharmacy, 67(6), 436-440. doi:10.4212/cjhp.v67i6.1406
Azia, I.N., Mukumbang, F.C., & Van Wyk, B. (2016). Barriers to adherence to
antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South
Africa. South African Journal HIV Medicine, 17(1), a476.
doi:10.4102/sajhivmed.v17i1.476
Beck, T.W. (201)3. The importance of a priori sample size estimation in strength and
conditioning research. The Journal of Strength & Conditioning Research,(8),
2323-37. doi: 10.1519/JSC.0b013e318278eea0
Beer, L., Bradley, H., Mattson, C.L., Johnson, C.H., Hoots, B., & Shouse, R.L. (2016).
Trends in racial and ethnic disparities in antiretroviral therapy prescription and
viral suppression in the United States, 2009–2013. Journal of Acquired Immune
Deficiency Syndrome, 73(4), 446–453. doi:10.1097/QAI.0000000000001125
Bekker, L. & Hosek, S. (2015). HIV and adolescents: Focus on young key populations.
Journal of International AIDS Society, 18(2Suppl. 1).
doi:10.7448/IAS.18.2.20076
Berger, M.B., Sullivan, K.A., Parnell, H.E., Keller, J., Pollard, A. & Cox, M. (2015).
Barriers and facilitators to retaining and reengaging HIV clients in care: A case
study of North Carolina. Journal of International Association of Providers of
AIDS Care, 5(6), 486-493. doi:10.1177/2325957415616491
Bernard, S., Tailor, A., Jones, P., & Alexander, D.E. (2016). Addressing the

99
medical and support service needs of people living with HIV (PLWH) through
program collaboration and service integration (PCSI). California Journal of
Health Promotion, 14(1), 1-14
Boston University Medical Center. (2018). The social cognitive theory. Retrieved from
http://sphweb.bumc.bu.edu/otlt/MPH-Modules/SB/BehavioralChangeTheories/
BehavioralChangeTheories5.html
Braveman, P. & Gottlieb, L. (2014). The social determinants of health: It's time to
consider the causes of the causes. Public Health Reports, 129(2), 19-31. doi:
10.1177/00333549141291S206
Carey, J.W., Carnes, N., Schoua-Glusberg, A., Kenward, K., Gelaude, D., & Denson D.,
(2018). Barriers and facilitators for clinical care engagement among HIV-positive
African American and Latino men who have sex with men. AIDS Patient Care
STDS, 32(5), 191-201. doi:10.1089/apc.2018.0018
Caruana, E., Roman, M., Hernández-Sánchez, J., & Solli, P. (2015). Longitudinal
studies. Journal of Thoracic Disease, 7(11), E537-E540. doi:10.3978/j.issn.20721439.2015.10.63
Castel, A., Kalmin, M., Hart, L.D., Young, H.A., Hays, H., & Benator, D. (2016)
Disparities in achieving and sustaining viral suppression among large cohort of
HIV-infected persons in 2019 Novel Coronavirus Responsecare - Washington,
DC. AIDS Care 28(11), 13551364. doi:10.1080/09540121.2016.1189496
Centers for Disease Control and Prevention. (2012a). Medical monitoring project

100
2012 protocol. Retrieved from https://www.cdc.gov/hiv/pdf/statistics/
systems/mmp/research_mmp_protocol_2012.pdf
Centers for Disease Control and Prevention. (2012b). 2012 standard questionnaire for
medical monitoring project (MMP). Retrieved from https://www.cdc.gov/
hiv/pdf/statistics/systems/mmp/research_mmp_questionnaire_2012.pdf
Centers for Disease Control and Prevention. (2014). National center for HIV/AIDS, viral
hepatitis, STD, and TB prevention social determinants of health. Retrieved from
https://www.cdc.gov/nchhstp/socialdeterminants/faq.html
Centers for Disease Control and Prevention. (2016). New HIV infections in the United
States. Retrieved from https://www.cdc.gov/nchhstp/newsroom/docs/
factsheets/new-hiv-infections-508.pdf
Centers for Disease Control and Prevention. (2017). HIV among African Americans.
Retrieved from https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/cdc-hivaa-508.pdf
Centers for Disease Control and Prevention. (2018a). HIV and gay and bisexual men.
Retrieved from https://www.cdc.gov/hiv/group/msm/index.html.
Centers for Disease Control and Prevention. (2018b). Anal sex and HIV risk. Retrieved
from https://www.cdc.gov/hiv/risk/analsex.html
Centers for Disease Control and Prevention. (2018c). HIV among youth. Retrieved from
https://www.cdc.gov/hiv/group/age/youth/index.html
Center for Disease Control and Prevention. (2019). Prevention for persons with HIV.

101
Retrieved from https://www.cdc.gov/hiv/clinicians/treatment/partnerprevention.html
Center for Innovation in Research and Teaching. (n.d.). Analyzing quantitative research.
Retrieved from https://cirt.gcu.edu/research/developmentresources/research
_ready/quantresearch/analyze_data
Centers for Media and Child Health. (2018). Media and young adults. Retrieved from
http://cmch.tv/parents/young-adults-ages-20-25/
Chakrabarti, S. (2014). What’s in a name? Compliance, adherence and concordance in
chronic psychiatric disorders. World Journal of Psychiatry,4(2): 30–36.
doi: 10.5498/wjp.v4.i2.30
Chang, H. & Phillips, M. (2014). Secondary analysis of existing data: opportunities
and implementation. Shanghai Archives Psychiatry, 26(6), 371–375. doi:
10.11919/j.issn.1002-0829.214171
Chaudry, A., Jackson, A. & Glied. (2019). Did the Affordable Care Act reduce racial
and ethnic disparities in health insurance coverage? The Commonwealth Fund.
https://doi.org/10.26099/d8hs-cm53
Chokshi, D.A. & Cohen, L. (2018). Income, poverty, and health inequality. Journal of
the American Medical Association, 319(13), 1312-1313.
doi:10.1001/jama.2018.2521
Coetzee, B., Kagee, A. & Bland, R. (2015). Barriers and facilitators to pediatric
adherence to antiretroviral therapy in rural South Africa: A multi-stakeholder
perspective. AIDS Care, 27(3):315-21. doi:10.1080/09540121.2014.967658

102
Colasanti,J., Kelly, J., Pennisi, E., Hu, Y.J., Root, C., Hughe, D. (2015)
Continuous Retention and viral suppression provide further insights into the HIV care
continuum compared to the cross-sectional HIV care cascade. Conical Infectious
Disease, 62(5), 648–654.
Cook, C.L., Canidate, S., Ennis, N. & Cook, R.L. (2018). Types and delivery of
emotional support to promote linkage and engagement in HIV care. Patient
Preference and Adherence, 12, 45–52. doi:10.2147/PPA.S145698
Crepaz, N., Dong, X., Wang, X., Hernandez, A.L. & Hall, H.I. (2018). Racial and ethnic
disparities in sustained viral suppression and transmission risk potential among
persons receiving HIV care - United States, 2014. MMWR Morbidity & Mortality
Weekly Report, 67, 113–118. doi.org/10.15585/mmwr.mm6704a2
Creswell, J. (2014). Research design: Qualitative, quantitative, and mixed methods
approaches (4th ed). Thousand Oaks, CA: Sage publications.
Dahiru, T. (2008). P-value, a true test of statistical Significance? A cautionary note.
Annual Ibadan Postgraduate Medicine, 6(1), 21–26. Retrieved from
https://www.ncbi.nlm.nih.gov /pmc/articles/PMC41110
Dasqupta, S., Kramer, M.R., Rosenberg, E.S., Sanchez, T.H., Reed, L., & Sullivan, P.S.
(2015). The effect of commuting patterns on HIV care attendance among men
who have sex with men (MSM) in Atlanta, Georgia. JMIR Public Health
Surveillance, 1(2), e10. doi:10.2196/publichealth.4525
del Amo J., Lodi, S., Dray-Spira, R., Wittkop, L., Monge, S., & Braun, D. (2017).
Inequalities by educational level in response to combination antiretroviral

103
treatment and survival in HIV-positive men and women in Europe (1996-2013).
AIDS, 31(2), 253-262. doi:10.1097/QAD.0000000000001270
Dawson, L. & Kates, J. (2019). An update on insurance coverage among people with
HIV in the United States. Kaiser Family Foundation. Retrieved from
https://www.kff.org/report-section/an-update-on-insurance-coverage-amongpeople-with-hiv-in-the-united-states-findings/
Devi, S. & Kalia, A. (2015). Study of data cleaning & comparison of data cleaning Tools.
International Journal of Computer Science and Mobile Computing, 4(3), 260.
Retrieved from
https://www.ijcsmc.com/docs/papers/March2015/V4I3201599a30.pdf
Dombrowski, J. & Kinney, R. (2017). National HIV curriculum: Linkage to HIV care.
Retrieved from https://www.hiv.uw.edu/go/screening-diagnosis/linkagecare/core-concept/all
Eaton, L., Driffin, D., Kegler, C., Smith, H.., Conway-Washington, C., White, D., &
Cherry, C. (2015). The role of stigma and medical mistrust in the routine health
care engagement of African American men who have sex with men. American
Journal of Public Health, 105(2), e75–e82. doi:10.2105/AJPH.2014.302322
El-Rachidi, S., LaRochelle, J., & Morgan, J. (2017). Pharmacists and pediatric
medication adherence: bridging the gap. Hospital Pharmacy, 52(2), 124–131.
doi:10.1310/hpj5202-124
Dodd-Mclure, A. & Taraglia, A (n.d.). Self-Reported bias: learning to live with its

104
diagnosis in chaplaincy research. Retrieved from http://www.professional
chaplains. org/files/publications/Chaplaincy_today_online/volume_26
/number_1/26_1doddmccue.pdf
Faber, J. & Fonseca, L. M. (2014). How sample size influences research outcomes.
Dental Press Journal of Orthodontics, 19(4), 27-29. doi:10.1590/21769451.19.4.027-029.ebo
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009). Statistical power analyses
using G*power 3.1: tests for correlation and regression analyses. Behavior
Research Methods, 41, 1149-1160.
Fink, A. (2015). Wanted! valid and meaningful data as proof of best available
Evidence. In Fink, A.Evidence-based public health practice (pp. 159-210).
Thousand Oaks, CA: Sage. Retrieved from Walden University.
Fisher, C.B., Fried, A.L., Macapagal, K. & Mustanskic, B. (2018). Patient-Provider
communication barriers and facilitators to HIV and STI preventive services for
adolescent MSM. AIDS Behavior, 22(10), 3417–3428. doi:10.1007/s10461-0182081-x
Firestone, R., Rivas, J., Lungo, S., Cabrera, S., Ruether, S., & Wheeler, J. (2014).
Effectiveness of a combination prevention strategy for HIV risk
reduction with men who have sex with men in Central America: a mid-term
evaluation. BioMed Central Public Health, 14, 1244. doi.org/10.1186/1471-245814-1244
Frances, Thirumoorthy, & Kwan (2016). Medication adherence in the elderly. Journal of
Clinical Gerontology and Geriatrics,7(2), 64-67

105
Frankfort-Nachmias, C., & Leon-Guerrero, A. (2015). Social statistics for a diverse
society (7th ed.). Thousand Oaks, CA: Sage Publications.
Galvan, F., Bogart, L., Klein, D., Wagner, G. & Chen, Y. (2017). Medical mistrust as a
key mediator in the association between perceived discrimination and adherence
to antiretroviral therapy among HIV-positive Latino men. Journal of Behavioral
Medicine, 40, 84–793. doi:10.1007/s10865-017-9843-1
Genberg et al. (2016). Improving engagement in the HIV care cascade: A systematic
review of interventions involving people living with HIV/AIDS as peers. AIDS
Behavior, 20(10), 2452–2463. doi:10.1007/s10461-016-1307-z
Georgia Department of Public Health, HIV/AIDS Epidemiology Section Medical
Monitoring Project Surveillance Summary: Behavioral and Clinical
Characteristics of Persons Receiving HIV Care in Georgia, 2009-2013. Retrieved
from https://dph.georgia.gov/data-fact-sheet-summaris
Georgia Department of Public Health. (2017). Georgia Integrated HIV Prevention & Care
Plan 2017-202. Retrieved from https://dph.georgia.gov/ sites/dph.georgia
.gov/files/ Georgia%20Integrated%20HIV%20Prevention%20 and%20
Care%20Plan%20CY%202017-2021.pdf
Glanz, K., Rimer, B., & Viswanath, K. (Eds). (2015). Health Behavior: Theory, research,
and practice (5th ed). San Francisco, CA: Jossey-Bass.
Goodin et al. (2018). Intersectional health-related stigma in persons living with HIV and
chronic pain: implications for depressive symptoms. AIDS Care, 30(2), 66-73,
doi:10.1080/09540121.2018.1468012

106
Gourlay et al. (2017). A qualitative study exploring the social and environmental context
of recently acquired HIV infection among men who have sex with men in SouthEast England. BMJ Open, 7(8), e016494. doi:10.1136/bmjopen-2017-016494
Govind et al. (2017). Adherence to antiretroviral therapy and factors affecting adherence
among paediatric HIV patients. International Journal of Contemporary
Pediatrics, 4(6). doi.org/10.18203/2349-3291.ijcp20174154
Grant, C. & Osanloo, A. (2014). Understanding, selecting, and integrating a theoretical
framework in dissertation research: Creating the blueprint for your “house”.
Administrative Issues Journal, 4(2), 1-26. doi:10.5929/2014.4.2.9
Grey et al. (2016). Estimating the population sizes of men who have sex with men in
US States and counties using data from the American community survey. JMIR of
Public Health Surveillance, 2(1), e14. doi:10.2196/publichealth.5365
Gross, I., Hosek, S., Richards, M. & Fernandez, M.I. (2016). Predictors and profiles of
antiretroviral therapy adherence among African American adolescents and young
adult males living with HIV. AIDS Patient Care and STDS, 30(7), 324–338. doi:
10.1089/apc.2015.0351
Health Resources and Services Administration. (2017). Part B: AIDS drug assistance
program. Retrieved from https://hab.hrsa.gov/about-ryan-white-hivaidsprogram/part-b-aids-drug-assistance-program
Healthy People 2020. (2018a). Social determinants of health. Retrieved from
https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinantsof-health

107
Healthy People 2020. (2018b). Determinants of health. Retrieved from
https://www.healthypeople.gov/2020/about/foundation-healthmeasures/determinants-of-health
Henderson, B.C. & Egbert, A. (2015). Young Adults in Minnesota: A demographic &
economic Profile. Minnesota state demographic center, population notes.
Retrieved from https://mn.gov/admin/assets/young-adults-in-mn-profilepopnotes-june2015_tcm36-219658.pdf
Hightow-Weidman et al. (2017). Exploring the HIV continuum of care among young
African American MSM. Plos ONE, 12(6):e0179688. doi:
10.137/journal.pone.0179688
HIV.gov. (n.d.). The Affordable Care Act and HIV/AIDS. Retrieved from
https://www.hiv.gov/federal-response/policies-issues/the-affordable-care-act-andhiv-aids
Hornschuh, S., Dietrich, J.J., Tshabalala, C. & Laher, F. (2017). Antiretroviral treatment
adherence: Knowledge and experiences among adolescents and young adults in
Soweto, South Africana. AIDS Research and Treatment, 5192516, 8.
doi.org/10.1155/2017/5192516
Hussen et al. (2015). Psychosocial influences on engagement in care among HIVpositive young Black gay/bisexual and other men who have sex with men. AIDS
Patient Care STDS, 29(2), 77–85. doi:10.1089/apc.2014.0117
Iacob, S., Iacob, D. & Jugulete. G. (2017). Improving the adherence to antiretroviral

108
hterapy, a difficult but essential task for a successful HIV treatment - clinical
points of view and practical considerations. Frontiers in Pharmacology, 8(831).
doi:10.3389/fphar.2017.00831
Institute for Digital Research and Education. (2019). Introduction in power analysis.
Retrieved from https://stats.idre.ucla.edu/other/mult-pkg/seminars/intro-power/.
Isenalumhe, L., Fridgen, O., Beaupin, L.K., Quinn, G.P. & Reed, D.R. (2016). Disparities
of adolescent and young adult patients in the treatment of malignant hematologic
diseases. Sage Journals, 23(4), 424-433. doi.org/10.1177/107327481602300414
Kahamba, J., Massawe, F. & Jeckoniah, C. (2017). HIV-infected gay men and
adherence to HIV antiretroviral tmerapies. In W. Leo (Ed.) Understanding
prevention for HIV positive gay Men: Innovative approaches in addressing the
AIDS epidemic (pp. 151-192). Binghamton, NY: Springer.
Kahana, S., Jenkins, R., Bruce, D., Fernandez, M. Hightow-Weidman, L.B., &
Bauermeister, A. (2016). Structural determinants of antiretroviral therapy use,
HIV care attendance, and viral suppression among adolescents and young adults
living with HIV. PLOS One, 11(4), e0151106. doi: 10.1371/journal.pone.0151106
Kalichman, S. (2016). Race-Based medical mistrust, medication beliefs and HIV
treatment adherence: Test of a mediation model in people living with HIV/AIDS.
Journal of Behavioral Medicine, 39(6), 1056–1064. doi:10.1007/s10865-0169767-1
Kang, H. (2013). The prevention and handling of the missing data. Korean Journal of
Anesthesiology, 64(5), 402–406. doi:10.4097/kjae.2013.64.5.402

109
Kates, J. & Dawson, L. (2017). Insurance Coverage Changes for People with HIV Under
the ACA. Kaiser Family Foundation Issue Brief. Retrieved from
https://www.kff.org/health-reform/issue-brief/insurance-coverage-changes-forpeople-with-hiv-under-the-aca/
Kay, E., Batey, D.S. & Mugavero, M. (2016). The HIV treatment cascade and care
continuum: updates, goals, and recommendations for the future. AIDS Research
and Theory, 13(35). doi:10.1186/s12981-016-0120-0
Kent State University. (2017). Recoding Transforming Variables. Retrieved from
https://libguides.library.kent.edu/SPSS/RecodeVariables
Kent State University. (2019). SPSS Tutorials: Chi-square Test of Independence.
Retrieved from https://libguides.library.kent.edu/SPSS/ChiSquare
Khang, H. (2013). The prevention and handling of the missing data. Korean Journal of
Anesthesia, 64(5): 402–406. doi:10.4097/kjae.2013.64.5.402
Kim, S., Gerver, S., Fidler, S. & Ward, H. (2014). Adherence to antiretroviral therapy in
adolescents living with HIV: systematic review and meta-analysis. AIDS, 28(13),
1945–1956. doi:10.1097/QAD.0000000000000316
Kirkegaard, J. (2010). How Europe can muddle through its crisis (Policy brief 10-27).
Washington, D.C. Peterson Institute for International Economics.
Kurth, A. Lally, M., Choko, A., Inwani, I. & Fortenberry, J. (2015). HIV testing and
linkage to services for youth. Journal of the International AIDS Society, 8(2),
19433. doi:10.7448/IAS.18.2.19433
Lacey, M., Hanna, G. Miller, J., Foster, T., & Russell, M. (2014). Impact of

110
pharmaceutical innovation in HIV/AIDS treatment during the highly active
antiretroviral therapy (HAART) era in the US, 1987-2010: An epidemiologic and
cost-impact modeling case study. Retrieved from
http://truvenhealth.com/Portals/0/Assets/Life-Sciences/White-Papers/pharmainnovation-hiv-aids-treatment.pdf
Lall, P., Lim, S. Khairuddin, N. & Kamarulzaman, A. (2015). Review: An urgent need
for research on factors impacting adherence to and retention in care among HIVpositive youth and adolescents from key populations. Journal of International
AIDS Society, 18(2Suppl 1), 19393. doi:10.7448/IAS.18.2.19393
Lambert, C., Mugavero, M., Najjar, Y., Enah, C. & Guthrie, B. (2018). The state of
adherence to HIV care in African American Women. Journal of the Association
of Nurses in AIDS Care, 29(4), 487-503. doi.org/10.1016/j.jana.2018.02.008.
Lammers, W.J. & Badina, P. (2013). Chapter 7 sampling techniques. In W.J. Lammers &
P. Badina (Eds.), Fundamentals of Behavioral Research Textbook (pp. 7-1-7-23).
Wadsworth. Retrieved from https://uca.edu/psychology/files/2013/08/Ch7Sampling-Techniques.pdf
Author, A. A., & Author, B. B. (Year of publication). Title of chapter. In E. E.
Editor & F. F. Editor (Eds.), Title of work: Capital letter also for subtitle (pp.
pages of chapter). Publisher.
Lang, M., David, V. & Giese-Davis, J. (2015). The age conundrum: A scoping review

111
of younger age or adolescent and young adult as a risk factor for clinical distress,
depression, or anxiety in cancer. Journal of Adolescent and Young Adult
Oncology, 4(4), 157-173. doi:10.1089/jayao.2015.0005
Langkamp, D. L., Lehman, A., & Lemeshow, S. (2010). Techniques for handling missing
data in secondary analyses of large surveys. Academic Pediatrics, 10(3), 205–210.
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866831/
Lee, C., Famoye, F., Sheldon, B. & Brown, A. (n.d.). Tutorials and clips. SPSS on-line
training workshop. Retrieved from http://calcnet.mth.cmich.edu/org
/spss/basic.htm
Lindenfeld, J. & Jessup, M. (2017). “Drugs don't work in patients who don't take them”
(C. Everett Koop, MD, US Surgeon General, 1985). European Journal of Heart
Failure, 9(11), 1412-1413. doi.org/10.1002/ejhf.920
Liu et al. (2016). Barriers and facilitators of linkage to and engagement in HIV care
among HIV-positive men who have sex with men in China: A qualitative study.
AIDS Patient Care STDS, 30(2), 70–77. doi:0.1089/apc.2015.0296
Ludema et al. (2017). Impact of health insurance, ADAP, and income on HIV viral
suppression among US women in the women’s interagency HIV study, 2006–
2009. Journal of Acquire Immune Deficiency Syndrome, 73(3), 307–312. doi:
10.1097/QAI.0000000000001078
Machimba et al. (2013). Behavioral disinhibition and sexual risk behavior among
adolescents and young adults in Malawi. Plos Ones, 8(9), e73574.
doi.org/10.1371/journal.pone.0073574

112
Marateb, H.R., Mansourian, M., Adibi, P., & Farina, D. (2014). Manipulating
measurement scales in medical statistical analysis and data mining: A review of
methodologies. Journal of Research in Medical Science, 19(1), 47–56.

Martinez-Mesa, J. Gonzalez-Cica, D., Duquia, R., Bonamigo, R. & Bastos, J. (2016).
Sampling: how to select participants in my research study? Anais Brasileiros De
Dermatologi, 91(3): 326–330. doi:10.1590/abd1806- 4841.20165254
Maskew et al. (2016). Insights into adherence among a cohort of adolescents aged 12–20
years in South Africa: Reported barriers to antiretroviral treatment. AIDS
Research and Treatment, 2016, 4161738. doi:10.1155/2016/4161738
Matsumoto et al. (2017). Social support as a key protective factor against depression in
HIV-infected patients: Report from large HIV clinics in Hanoi, Vietnam.
(Scientific Reports 7, Article Number:15489). Retrieved from
https://www.nature.com/articles/s41598-017-15768-w#ref-CR24
McCarthy et al. (2018). “How am I going to live?”: exploring barriers to ART adherence
among adolescents and young adults living with HIV in Uganda. BMC Public
Health, 18, 1158. doi.org/10.1186/s12889-018-6048-7
McDonagh, J. (2018). The age of adolescence…and young adulthood. The Lancet Child
and Adolescent Health, 2(4). doi.org/10.1016/S2352-4642(18)30079-8
McDonald, J.H. (2014). Handbook of Biological Statistics (3rd ed.). Baltimore,
Maryland: Sparky House Publishing. Retrieved from
http://www.biostathandbook.com/power.html

113
McGill, N. (2016). Education attainment linked to health throughout lifespan: Exploring
social determinants of health. The Nation’s Health, 46 (6) 1-19. Retrieved from
http://thenationshealth.aphapublications.org/content/46/6/1.3
McHugh, M. (2013). The chi-square test of independence. Biochem Medica, 23(2), 143149. doi:10.11613/BM.2013.018
McLeod, S. (2017). Qualitative vs quantitative. Simply Psychology. Retrieved from
https://www.simplypsychology.org/qualitative-quantitative.html
McMorrow, S., Kenney, G.M., Long, S.K. & Anderson, N. (2015). Uninsurance among
young adults continues to decline, particularly in Medicaid expansion states.
Health Affairs, 34 (4). doi.org/10.1377/hlthaff.2015.0044
Menard, S. (2010). Logistic regression: From introductory to advanced concepts and
applications (2nd ed). Thousand Oaks, CA: Sage Publications.
Micheni et al. (2017). Health provider views on improving antiretroviral therapy
adherence among men who have sex with men in Coastal Kenya. AIDS Patient
Care and STDs, 31(3), 113–121. doi:10.1089/apc.2016.0213
Mizuno, Y., Beer, L., Huang, P. & Frazier, E. (2017). Factors associated with
antiretroviral therapy adherence among transgender women receiving HIV
medical care in the United States. LGBT Health, 4(3).
doi.org/10.1089/lgbt.2017.0003
Molloy, G.J. & Carroll, R.E. (2017). Medication adherence across the lifespan: Theory,
methods, interventions and six grand challenges. Psychology & Health, 32(0), 1
169-1175. doi.org/10.1080/08870446.2017.1316850

114
Morrison, A., Stauffer, M., & Kaufman, A. (2015). Defining medication adherence in
individual patients. Patient Preference and Adherence, 9, 893–897. doi:
10.2147/PPA.S86249
Murray, K., Dulli, L. S., Ridgeway K., Dal Santo, L., Darrow de Mora, D., Olsen, P. et
al. (2017) Improving retention in HIV care among adolescents and adults in lowand middle-income countries: A systematic review of the literature. PLoS ONE
12(9), e0184879. doi.org/10.1371/journal.pone.0184879
Nachega, J. (2015). Association between antiretroviral therapy adherence and
employment status: Systematic review and meta-analysis. Bulletin of the World
Health Organization, 93(1), 29–41. doi:10.2471/BLT.14.138149
National Center for Educational Statistics. (2018). Educational attainment of young
adults. Retrieved from https://nces.ed.gov/programs/coe/indicator_caa.asp
National Institute of Allergy and Infectious Disease. (2017). 10 things to know about
HIV suppression. Retrieved from https://www.niaid.nih.gov/news-events/10things-know-about-hiv-suppression
National Institutes of Health. (2018). Considerations for antiretroviral use in special
patient populations: Adolescents and young adults with HIV. Retrieved from
https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescentarv/21/adolescents-and-young-adults-with-hiv
National Institutes of Health. (2018a). Adherence to antiretroviral therapy in children and
adolescents living with HIV. Retrieved from
https://aidsinfo.nih.gov/guidelines/html/2/pediatric-arv/83/adherence -to-

115
antiretroviral-therapy-in-children-and-adolescents-living-with-hiv
young-adults-with-hiv.
National Institutes of Health. (2018b). HIV and gay and bisexual men. Retrieved from
https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/25/81/hiv-and-gayand-bisexual-men
National Institutes of Health. (2018c). Considerations for antiretroviral use in special
patient populations: Adolescents and young adults with HIV. Retrieved from
https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescentarv/21/adolescents-and-young-adults-with-hiv
National Institutes of Health. (2019). HIV treatment: The basics. Retrieved from
https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/51/hiv-treatment-the-basics
Office of the Assistant Secretary for Planning and Evaluation. (2018). U.S. Federal
Poverty Guidelines Used to Determine Financial Eligibility for Certain Federal
Programs. Retrieved from https://aspe.hhs.gov/poverty-guidelines
Ogunbajo et al. (2018). Barriers, motivators, and facilitators to engagement in HIV care
among HIV-infected Ghanaian men who have sex with men (MSM). AIDS and
Behavior, 22(3), 829-839.doi.org/10.1007/s10461-017-1806-6
Palmer et al. (2018). Viral suppression and viral rebound among young adults living with
HIV in Canada. Medicine, 97(22), e10562. doi:0.1097/MD.0000000000010562
Pandhi, D. & Ailawadi, P. (2014). Initiation of antiretroviral therapy. Indian Journal of
Sexually Transmitted Diseases, 35(1), 1–11. doi:10.4103/0253-7184.132399

116
Pettifor et al. (2013). Preventing HIV among young people: Research priorities for the
future. Journal of Acquired Immune Deficiency Syndrome, 63(02), S155-S160.
doi:10.1097/QAI.0b013e31829871fb
Pike, G. R. (2008). Using weighting adjustments to compensate for survey nonresponse.
Research in Higher Education, 49(2), 153–171. doi:10.1007/s11162-007-9069-0
Pinheiroa et al. (2016). Aging, neurocognitive impairment and adherence to
antiretroviral therapy in human immunodeficiency virus-infected individuals.
Brazilian Journal of Infectious Diseases, 6. dx.doi.org/10.1016
/j.bjid.2016.09.006
Powell, D.J. & Xirasagar, S. (2017). Excess deaths among the uninsured before the
Affordable Care Act (ACA), and potential post-ACA reductions. Journal of
Public Health Management Practices. 23(3), e18-e28. doi:
10.1097/PHH.0000000000000428
Puskas et al. (2017). The adherence gap: a longitudinal examination of men's and
women's antiretroviral therapy adherence in British Columbia, 2000–2014. AIDS
International Society, 31(6), 827-833. doi:0.1097/QAD.0000000000001408
Qiao, S., Zhou, G. & Li, X. (2018). disclosure of same-sex behaviors to health-care
providers and uptake of HIV testing for men who have sex with men: A
systematic review. American Journal of Men’s Health, 12(5), 1197-1214.
doi.org/10.1177/1557988318784149
Qiao, S., Zhou, G. & Li, X. (2018). Disclosure of Ssme-sex behaviors to health-care

117
providers and uptake of HIV testing for men who have sex with men: A
systematic review. American Journal of Men’s Health, 12(5), 1197-1214.
doi.org/10.1177/1557988318784149
Quinn et al. (2018). Multiple dimensions of stigma and health related factors among
young African American men who have sex with men. AIDS Behavior, 21(1).
207–216. doi:10.1007/s10461-016-1439-1
Rachidi, S. LaRochelle, J. & Morgan, J. (2017). Pharmacists and pediatric medication
adherence: Bridging the gap. Hospital Pharmacy, 52(2), 124–131. doi:
10.1310/hpj5202-124
Salazar, L. F., Crosby, R. A., & DiClemente, R. J. (2015). Research methods in health
promotion (2nd ed). San Francisco, CA: John Wiley & Sons.
Salkind, N. (2010). Stratified Sampling. Encyclopedia of Research Design
(Vols. 1-0). Thousand Oaks, CA: SAGE Publications.
doi.org/10.4135/9781412961288
Sangaramoorthy, T., Jamison, A. & Dyer, T. (2017). Intersectional stigma among midlife
and older African American women living with HIV. Culture, Health &
Sexuality, 12(12), 1329-1343. doi:10.1080/13691058.2017.1312530
Schlomer, B.J. & Copp, H.L. (2014). Secondary data analysis of large data sets in
urology: Successes and errors to avoid. The Journal of Urology, 91(3), 587–596.
doi:10.1016/j.juro.2013.09.09.1
Shaw, S. & Amico, K. (2016). Antiretroviral therapy adherence enhancing
interventions for adolescents and young adults 13–24 years of age: A review
of the evidence base. Journal of Acquired Immune Deficiency Syndrome, 72:4,

118
387-399. doi:10.1097/QAI.0000000000000977
Singh et al. (2017). Men living with diagnosed HIV who have sex with men: Progress
along the continuum of HIV care - United States, 2010. MMWR Morbidity
Mortality Weekly Report, 66. 969–974. doi.org/10.15585/mmwr.mm6637a2
Schlatter, A., Deathe, A. & Vreeman, I. (2016). The need for pediatric formulations to
treat children with HIV/AIDS. AIDS Research and Treatment, Article ID
1654938, 8. doi:10.1155/2016/1654938
Sommers, B., Gawande, A. & Baicker, K. (2017). Health insurance coverage and health
-what the recent evidence tells us. New England Journal of Medicine, 377, 586593, doi:10.1056/NEJMsb1706645
Soomro, N., Fitzgerald, G., Seeley, J., Schatz, J.E., Nachega, J.E., & Negin, J.
(2018). Comparison of antiretroviral therapy adherence among HIVinfected AIDS and behavior, older adults with younger adults in Africa:
systematic review and meta-analysis. AIDS Behavior, 1-14.
doi.org/10.1007/s10461-018-2196-0
Spencer, D.L., McManus, M., Call, K.T., Turner, J.M., Harwood, C., & White, P. (2018).
Health care coverage and access among children, adolescents,
and young adults, 2010–2016: Implications for future health reforms adolescent
health. Journal of Adolescent Health, 62(6): 667–673. doi:
10.1016/j.jadohealth.2017.12.012
Stahre, M., VanEenwyk, J., Siegel, Paul, & Njai, R. (2015). Housing insecurity and the

119
association with health outcomes and unhealthy behaviors, Washington State,
2011. Preventing Chronic Disease, 12, E109. doi:10.5888/pcd12.140511
Stevens, R., Icar, L., Jemmott, J.B., O'Leary, A., Rutledge, S., & Hsu, J., (2017). Risky
trade: Individual and neighborhood level socio-demographics associated with
transactional sex among urban African American MSM. Journal of Urban Health,
94. doi:10.1007/s11524-017-0187-5
Stoltzfus, J.C. (2011). Logistic regression: A brief primer. Academy of Emergency
Medicine, 18(10), 1099-104. doi:10.1111/j.1553-2712.2011.01185
Szumilas, M. (2010). Explaining odds ratios. Journal of Canadian academy of child and
adolescent psychiatry, 19(3), 227–229.
Tebb, K. T., Pica, G., Twietmeyer, L., Diaz, A. & Brindis, C.D. (2017). Addressing
social determinants of health among adolescents and young adults strategies from
the field: Philip R. Lee Institute for Health Policy Studies and Division of
Adolescent and Young Adult Medicine, Department of Pediatrics.
(Bulletin, June 2017). San Francisco: University of California. Retrieved from
http://www.amchp.org/programsandtopics/AdolescentHealth/Documents/JuneJulyAYAHCenterBulletin.pdf
Tumwikirize, S., Torpey, K., Adedokun, O. & Badru, T. (2015). The value of support
group participation in influencing adherence to antiretroviral treatment among
people living with human immunodeficiency virus (HIV). World Journal of AIDS,
5, 189-198. doi.org/10.4236/wja.2015.53022
UCLA Institute of Digital Research and Education. (2016). Missing data | SPSS learning

120
modules. Retrieved from https://stats.idre.ucla.edu/spss/modules/missing-data
United State Census Bureau. (2018a). Another look at health insurance coverage rates
for young adults. Retrieved from https://www.census.gov /newsroom/
blogs/random-samplings/2018/09/another_look_at_heal.html.l
United States Census Bureau. (2018b). American community survey: Comparing 2017
American community survey data. Retrieved from
https://www.census.gov/data/tables/2017/demo/education-attainment/cpsdetailed-tables.html
United States Department of Health and Human Services. (2016). HIV care continuum.
Retrieved from https://www.hiv.gov/federal-response/policies-issues/hiv-aidscare-continuum
Voisin, D.R., Quinn, K., Kim, D.H., & Schnieder, J. (2017). A longitudinal analysis of
medication adherence among young African American men who have sex with
men: A latent class analysis. Journal of Adolescent Health, 60(4), 411-416. doi:
10.1016/j.jadohealth.2016.10.428
Whiteley, L., Brown, L, Lally, M., Heck, N. & van den Berg, J. (2018). A mobile
gaming intervention to increase adherence to antiretroviral treatment for youth
living with HIV: Development guided by the Information, motivation, and
behavioral skills model. Journal of Medical Internet Research Mhealth Uhealth,
6(4), e96. doi:10.2196/mhealth.8155
World Health Organization. (2017). HIV: from a devastating epidemic to a manageable

121
chronic disease. Retrieved from https://www.who.int/publications/10-yearreview/chapter-hiv.pdf?ua=1
World Health Organization. (2018a). About social determinants of health. Retrieved from
https://www.who.int/social_determinants/sdh_definition/en/
World Health Organization. (2018b). Health Impact Assessment: The determinants of
Health. Retrieved from https://www.who.int/hia/evidence/doh/en/
Xu et al. (2017). Factors influencing antiretroviral treatment suboptimal adherence
among perinatally HIV-infected adolescents in Thailand. PLOS ONE, 12(2):
e0172392. doi.org/10.1371/journal.pone.0172392
Yahima et al. (2014). Retention in care is more strongly associated with viral
suppression in HIV-infected patients with lower versus higher CD4 counts.
Journal of Acquire Immune Deficiency Syndrome, 65(3), 333–339. doi:
10.1097/QAI.0000000000000023
Yang et al. (2018). Medication adherence to antiretroviral therapy among newly treated
people living with HIV. BioMed Central Public Health, 18(825). doi:
0.1186/s12889-018-5731-z
Yap, A. Thirumoorthy, T. & Kwan, Y.M. (2016). Medication adherence in the elderly.
Journal of Clinical Gerontology and Geriatrics, 7(2), 64-67.
doi.org/10.1016/j.jcgg.2015.05.001
Yehia et al. (2015). Barriers and facilitators to patient retention in HIV care. BMC
Infectious Disease, 12, 256. doi.org/10.1186/s12879-015-0990-0
Zanoni, B. & Mayer, K.H. (2014). The adolescent and young adult HIV cascade of

122
care in the United States: Exaggerated health disparities. AIDS Patient Care
STDS, 28(3), 128–135. doi:10.1089/apc.2013.0345
Zhou et al. (2014). Treatment Adherence and health outcomes in MSM with HIV/AIDS:
Patients enrolled in ‘‘One-Stop’’ and standard care clinics in Wuhan China. PLoS
ONE 9(12): 113736. doi:10.1371/journal.pone.01137

123
Appendix A: Chi-square Output
Table A1
Results of Awareness Dose Adherence When Taking ART Medicine Crosstabulation

Awareness

Aware

Count
% within Awareness
% within 100% Dose
adherence when taking
ART medicine
% of Total
Not Aware Count
% within Awareness
% within 100% Dose
adherence when taking
ART medicine
% of Total
Total
Count
% within Awareness
% within 100% Dose
adherence when taking
ART medicine
% of Total
Source: Wortley & Drenzek, 2015

100% Dose adherence when
taking ART medicine
Yes, person No, person is
is 100%
not 100%
adherent
adherent
52
11
82.5%
17.5%
77.6%
84.6%

Total
63
100.0%
78.8%

65.0%
15
88.2%
22.4%

13.8%
2
11.8%
15.4%

78.8%
17
100.0%
21.3%

18.8%
67
83.8%
100.0%

2.5%
13
16.3%
100.0%

21.3%
80
100.0%
100.0%

83.8%

16.3%

100.0%

Table A2
Results of Awareness Instruction Adherence When Taking ART Medicine Crosstabulation
(table continues)
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Awareness

Aware

Count
% within Awareness
% within 100%
Instruction adherence
when taking ART
medicine
% of Total
Not Aware Count
% within Awareness
% within 100%
Instruction adherence
when taking ART
medicine
% of Total
Total
Count
% within Awareness
% within 100%
Instruction adherence
when taking ART
medicine
% of Total
Source: Wortley & Drenzek, 2015

100% Instruction adherence
when taking ART medicine
Yes, person No, person is
is 100%
not 100%
adherent
adherent
36
14
72.0%
28.0%
92.3%
70.0%

Total
50
100.0%
84.7%

61.0%
3
33.3%
7.7%

23.7%
6
66.7%
30.0%

84.7%
9
100.0%
15.3%

5.1%
39
66.1%
100.0%

10.2%
20
33.9%
100.0%

15.3%
59
100.0%
100.0%

66.1%

33.9%

100.0%

Table A3
Results of Awareness Schedule Adherence When Taking ART Medicine Crosstabulation
100% Schedule adherence
when taking ART
Total (table
medicine
continues)
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Awareness

Aware

Count
% within Awareness
% within 100%
Schedule adherence
when taking ART
medicine
% of Total
Not Aware Count
% within Awareness
% within 100%
Schedule adherence
when taking ART
medicine
% of Total
Total
Count
% within Awareness
% within 100%
Schedule adherence
when taking ART
medicine
% of Total
% of Total
Source: Wortley & Drenzek, 2015

Yes, person No, person
is 100%
is not 100%
adherent
adherent
50
13
79.4%
20.6%
83.3%
65.0%

63
100.0%
78.8%

62.5%
10
58.8%
16.7%

16.3%
7
41.2%
35.0%

78.8%
17
100.0%
21.3%

12.5%
60
75.0%
100.0%

8.8%
20
25.0%
100.0%

21.3%
80
100.0%
100.0%

75.0%
66.1%

25.0%
33.9%

100.0%
100.0%
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Appendix B: Regression Output
Table B1
Results of Parameter Estimates for Social Determinates and Predicting Medication Instruction
Adherence

100% Instruction adherence
when taking ART medicinea
Intercept
[Age groups at
Yes, person is interview
100% adherent date=1]
[Age groups at
interview
date=2]
[Age groups at
interview
date=3]
[Age groups at
interview
date=4]
[Race/Ethnicit
y=1]
[Race/Ethnicit
y=2]
[Race/Ethnicit
y=9]
[Highest level
of
education=3]

Std.
B
Error Wald
2.058
.894 5.298
.513
.653 .618

df

95% Confidence Interval
for Exp(B)
Exp(
Upper
B)
Lower Bound Bound

Sig.
1 .021
1 .432 1.670

.465

6.002

-.118

.561

.044

1

.834

.889

.296

2.667

.061

.547

.013

1

.911 1.063

.364

3.109

0b

.

.

0

.

.

.

.

.818 4.745

1

.029

.168

.034

.836

.647

.514

1

.473

.629

.177

2.235

.

.

0

.

.

.

.

.841 3.925

1

.048

1.781
-.464
0b
1.667

.982
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[Highest level
of
education=4]

-.342

.751

.208

1

.649

.710

.163

3.093

[Highest level
of
education=5]
[Highest level
of
education=6]
[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=1]
[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=2]

1.407

.641 4.818

1

.028

.245

.070

.860

.

0

.

.

.

.

.441 1.444

1

.229 1.699

.716

4.030

1

.804 1.372

.112 16.796

0b

.530

.316

.

1.278

.061

(table continues)
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[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=3]
Source: Wortley & Drenzek, 2015

0b

.

.

0

.

.

.

Table B2
Results of the Pseudo R-Square for Social Determinates and Predicting Medication
Instruction
Cox and Snell
.117
Nagelkerke
.165
McFadden
.101
Source: Wortley & Drenzek, 2015
Table B3
Results of the Parameter Estimates Results for Social Determinates and Predicting
Medication Schedule Adherence

100% Schedule adherence
when taking ART medicinea
Intercept
Yes, person is
100%
[Age groups
adherent
at interview
date=1]

Std.
B
Error Wald
18.53
.664 778.16
5
8
-.460
.608
.573

df

Sig. Exp(B)
1 .000
1 .449

95% Confidence
Interval for Exp(B)
Lower
Upper
Bound
Bound

.631

.192 2.077
(table
continues)

.

129
[Age groups
at interview
.176
date=2]
[Age groups
.677
at interview
date=3]
[Age groups at
0b
interview
date=4]
[Race/Ethnicit .197
y=2]
[Race/Ethnicit
0b
y=9]
[Highest level
of
18.36
education=3]
6
[Highest level
of
18.11
education=4]
1
[Highest level
of
18.52
education=5]
9
[Highest level
0b
of
education=6]

.560

.098

1 .754

1.192

.398

3.569

.576

1.380

1 .240

1.968

.636

6.089

.

.

.

.

.

.

.583

.114

1 .735

1.218

.388

3.819

.

.

.

.

.

.671 748.74
1

1 .000 1.056E 2.834E-9
-8

3.936E-8

.481 1415.4
06

1 .000 1.363E 5.305E-9
-8

3.501E-8

.000

.

1

. 8.971E 8.971E-9
-9

8.971E-9

.

.

0

.

0

0

.

.

.

.

(table
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[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=1]
[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=2]
[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=3]

.829

.432

3.676

1 .055

2.291

.982

.334

1.249

072

1 .789

1.396

.121 16.138

0b

.

.

0

.

.

.

(table
continues)

5.347

.
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[Had any
health
insurance or
antiretroviral
medicines
(ARVs) were
paid by any
health
insurance in
the P12M=2]

.334

1.249

072

1 .789

1.396

Source: Wortley & Drenzek, 2015
Table B4
Results of the Pseudo R-Square for Social Determinants and Predicting Medication
Instruction Adherence
Cox and Snell
.168
Nagelkerke
.256
McFadden
.172
Source: Wortley & Drenzek, 2015

.121

16.138

